2-propanol has been researched along with Angiogenesis, Pathologic in 385 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion with that of aspirin." | 9.13 | Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. ( Farahvash, MM; Farahvash, MS; Mohammadzadeh, S; Moradimogadam, M, 2008) |
| "To evaluate the differences of ocular circulation in eyes with proliferative diabetic retinopathy (PDR) after panretinal photocoagulation (PRP) with or without rubeosis iridis." | 7.75 | [Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis]. ( Fujioka, S; Karashima, K; Saito, Y, 2009) |
| "From 43 Nepalese leprosy patients skin smear negative, and treated with dapsone (diamino diphenyl sulphone), and without any sign of active leprosy or iritis, specimens from iridectomy during cataract surgery were studied histopathologically." | 7.68 | Histopathological findings in the iris of dapsone treated leprosy patients. ( Brandt, F; Pradhan, H; Rai, N; Shi, ZR; Thuladar, L; Zhou, HM, 1990) |
| "223 complete eyes enucleated because of a malignant uveal melanoma were studied histologically to evaluate patterns of growth and invasion and secondary intraocular changes." | 7.68 | [Epidemiology, invasion and growth of non-iridic choroid melanomas and associated intraocular changes: histologic study of 223 eyes]. ( Kreissig, I; Rohrbach, JM; Steuhl, KP; Thiel, HJ, 1990) |
| "The clinical and histopathologic features of 29 eyes from 28 patients with central retinal vein occlusion (CRVO) are reported." | 7.66 | Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. ( Chan, CC; Green, WR; Hutchins, GM; Terry, JM, 1981) |
| "To compare the long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion with that of aspirin." | 5.13 | Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion. ( Farahvash, MM; Farahvash, MS; Mohammadzadeh, S; Moradimogadam, M, 2008) |
| " All patients received ocular treatment modality according to the presence of non-perfusion area (pan-retinal photocoagulation) and intraocular pressure (medical treatment included timolol maleate eye drops combined with brinzolamide eye drop; trabeculectomy and cyclophotocoagulation)." | 3.88 | Changes in Ocular Hemodynamics after Carotid Artery Angioplasty and Stenting (CAAS) in Patients with Different Severity of Ocular Ischemic Syndrome. ( Ma, F; Ma, H; Ma, J; Shang, Q; Su, J; Wang, X; Yu, J; Zhang, T, 2018) |
| "To evaluate the differences of ocular circulation in eyes with proliferative diabetic retinopathy (PDR) after panretinal photocoagulation (PRP) with or without rubeosis iridis." | 3.75 | [Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis]. ( Fujioka, S; Karashima, K; Saito, Y, 2009) |
| "Intravitreal triamcinolone acetonide may induce regression of iris neovascularization, increase intraocular pressure, and improve visual acuity in eyes presenting with ocular hypotony, vitreous hemorrhage, and progressive intraocular neovascularization due to ischemic ophthalmopathy." | 3.72 | Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy. ( Degenring, RF; Jonas, JB; Kreissig, I, 2003) |
| " Both eyes of these patients showed microaneurysms, multiple small blot hemorrhages, or capillary dilation in the temporal peripheral fundus." | 3.69 | Chronic ocular ischemia associated with the Eisenmenger's syndrome. ( Fukuda, M; Grunwald, JE; Harino, S; Motokura, M; Nishikawa, N; Sasaoka, A, 1994) |
| "From 43 Nepalese leprosy patients skin smear negative, and treated with dapsone (diamino diphenyl sulphone), and without any sign of active leprosy or iritis, specimens from iridectomy during cataract surgery were studied histopathologically." | 3.68 | Histopathological findings in the iris of dapsone treated leprosy patients. ( Brandt, F; Pradhan, H; Rai, N; Shi, ZR; Thuladar, L; Zhou, HM, 1990) |
| "223 complete eyes enucleated because of a malignant uveal melanoma were studied histologically to evaluate patterns of growth and invasion and secondary intraocular changes." | 3.68 | [Epidemiology, invasion and growth of non-iridic choroid melanomas and associated intraocular changes: histologic study of 223 eyes]. ( Kreissig, I; Rohrbach, JM; Steuhl, KP; Thiel, HJ, 1990) |
| "Photodynamic therapy using chloroaluminum sulfonated phthalocyanine (CASPc) effectively closed experimental iris neovascularization induced in 6 eyes of cynomolgus monkeys by argon laser retinal vein occlusion." | 3.68 | Phthalocyanine photodynamic therapy of experimental iris neovascularization. ( el-Koumy, HA; Gregory, WA; Miller, JW; Puliafito, CA; Stinson, WG, 1991) |
| "The antimetabolite 5-fluorouracil (5-FU) was used as adjunctive treatment in glaucomatous eyes with poor prognoses undergoing filtering surgery." | 3.67 | Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects. ( Weinreb, RN, 1987) |
| " The authors report their results using silicone oil in eyes with RD resulting from proliferative diabetic retinopathy (PDR) or proliferative vitreoretinopathy (PVR)." | 3.67 | Silicone oil in the treatment of complicated retinal detachments. ( Glaser, BM; Michels, RG; Yeo, JH, 1987) |
| "The clinical and histopathologic features of 29 eyes from 28 patients with central retinal vein occlusion (CRVO) are reported." | 3.66 | Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. ( Chan, CC; Green, WR; Hutchins, GM; Terry, JM, 1981) |
| "Of 93 eyes with proliferative diabetic retinopathy treated by argon laser panretinal photocoagulation, two (2." | 3.66 | Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. ( Augsburger, JJ; Magargal, LE; Tasman, W, 1980) |
| "Intraocular pressure was significantly (P < 0." | 2.70 | Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. ( Hayler, JK; Jonas, JB; Panda-Jonas, S; Söfker, A, 2001) |
| "Neovascular glaucoma is a serious complication associated with retinal ischemic changes, which increase the production of vascular endothelial growth factor." | 2.52 | [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma]. ( Ishibashi, S; Kondo, H, 2015) |
| "Neovascular glaucoma is defined as an iris and/or anterior chamber angle neovascularization associated with increased intraocular presure." | 2.48 | [Neovascular glaucoma--etipathogeny and diagnosis]. ( Călugăru, D; Călugăru, M, 2012) |
| "Iris metastases were treated with 40 Gray of radiation therapy and concurrent chemotherapy." | 1.62 | Iris metastasis as the initial presentation of metastatic esophageal cancer diagnosed by fine needle aspiration biopsy: A case report. ( Horiuchi, N; Kuribayashi, T; Kurihara, T; Ozawa, H; Smith, LEH; Takano, Y; Tomita, Y; Tsubota, K; Usui, Y, 2021) |
| "The eye is an important organ responsible for vision in most living organisms, and it is directly exposed to the atmosphere." | 1.48 | Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes. ( Akhtar, S; An, W; Gao, L; Kang, Y; Li, K; Sha, X; Zhang, X; Zhang, Y, 2018) |
| "The baby developed severe respiratory failure which required tracheostomy advanced bronchopulmonary dysplasia treated with steroids (BPD) and respiratory distress syndrome (RDS) with failure to extubate together with secondary ocular ischemia." | 1.40 | Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report. ( Kulik, U; Lubiński, W; Modrzejewska, M, 2014) |
| "Right intraocular pressure was markedly increased, and corneal edema and increased iris neovascularization were also recognized." | 1.39 | Deterioration of glaucoma after carotid endarterectomy. ( Fujimoto, A; Katsuta, T; Oba, K, 2013) |
| "A pterygium is characterized, amongst others, by fibrovascular proliferation and may have vision threatening consequences if left untreated." | 1.36 | Antivascular endothelial growth factors in anterior segment diseases. ( Augustin, AJ; Kirchhof, J; Scholl, S, 2010) |
| "She had type 2 diabetes for 15 years, with proliferative diabetic retinopathy that had been treated with panretinal photocoagulation." | 1.34 | Regression of neovascular posterior capsule vessels by intravitreal bevacizumab. ( Akova, YA; Eren, E; Küçükerdönmez, C; Yilmaz, G, 2007) |
| "Local treatment of uveal melanoma by radiotherapy involves the use of brachytherapy with radioactive plaques attached to the sclera, or proton irradiation." | 1.33 | Proton beam therapy and iris neovascularisation in uveal melanoma. ( Boyd, SR; Cree, IA; Errington, RD; Gittos, A; Hungerford, JL; Richter, M, 2006) |
| "Cataract was the earliest complication to appear." | 1.32 | Ocular complications after iodine brachytherapy for large uveal melanomas. ( Heikkonen, J; Kivelä, T; Puusaari, I, 2004) |
| "Neovascular glaucoma is a frequent complication of vitrectomy performed to treat proliferative diabetic retinopathy (PDR)." | 1.32 | Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy. ( Itakura, H; Kishi, S; Kotajima, N; Murakami, M, 2004) |
| "Sixteen patients with ischemic central retinal vein occlusion were followed up for 12 months by clinical examination, retinal and iris angiography, and serial anterior chamber sampling of aqueous humor." | 1.31 | Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. ( Allen, GJ; Boyd, SR; Chakravarthy, U; Cree, IA; Hykin, PG; Martin, JF; Wisdom, GB; Zachary, I, 2002) |
| "44 patients with a central retinal vein occlusion were examined with full field electroretinogram (ERG)." | 1.31 | Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion. ( Andréasson, S; Larsson, J, 2001) |
| "Neovascular glaucoma is a dreadful pathology with a rapid spontaneous evolution responsible for painful and blind eye." | 1.31 | [Consensus on neovascular glaucoma]. ( Baudouin, C; Hamard, P, 2000) |
| "Seven patients with central retinal vein occlusion were examined with full-field ERG within less than 24 hours after the onset of their symptoms and every second to third day during the first 3 weeks." | 1.31 | The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion. ( Andréasson, S; Bauer, B; Larsson, J, 2000) |
| "Results showed that recurrence of RVO in the same or fellow eye was decreased by more than half in the follow-up group (3." | 1.31 | Nine year follow-up study of morbidity and mortality in retinal vein occlusion. ( Dodson, PM; Kirwan, J; Kritzinger, EE; O'Leary, MB; Prior, P; Tsaloumas, MD; Vinall, H, 2000) |
| "In the management of cases of central retinal vein occlusion it is important to identify those patients who will develop the complication of iris neovascularisation." | 1.30 | Electroretinography of central retinal vein occlusion under scotopic and photopic conditions: what to measure? ( Bradnam, M; Keating, D; Williamson, TH, 1997) |
| "Laser retinal vein occlusion was used to produce retinal ischemia in 16 eyes of eight animals (Macaca fascicularis)." | 1.29 | Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. ( Adamis, AP; D'Amore, PA; Ferrara, N; Folkman, J; Gragoudas, ES; Miller, JW; Shima, DT; Tolentino, MJ, 1996) |
| "Patients with central retinal vein occlusion who later develop iris neovascularization show changes in the amplitude, the timing, and the sensitivity of the electroretinogram beta wave." | 1.29 | Rod photoreceptor transduction is affected in central retinal vein occlusion associated with iris neovascularization. ( Hood, DC; Johnson, MA, 1996) |
| "We conclude that neovascular glaucoma is more likely to occur in older subjects with CRVO." | 1.29 | Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion? ( Dodson, PM; Keenan, JM; Kritzinger, EE, 1993) |
| "Data from a population of patients with central retinal vein occlusion were used to examine the ability of the derived parameters to predict the development of neovascularization of the iris." | 1.29 | The care and fitting of Naka-Rushton functions to electroretinographic intensity-response data. ( Johnson, MA; Severns, ML, 1993) |
| "Two patients with ankylosing spondylitis (AS) and recurrent uveitis had rubeosis iridis each with an episode of spontaneous hyphema." | 1.28 | Spontaneous hyphema: an unusual complication of uveitis associated with ankylosing spondylitis. ( David, R; Klemperer, I; Yassur, Y, 1992) |
| "In five of the seven patients, the retinal hemorrhages appeared most florid in the territory of the obstructed arteriole, resulting initially in the consideration that these cases represented a combined branch retinal artery and branch retinal vein obstruction." | 1.28 | Combined branch retinal artery and central retinal vein obstruction. ( Brown, GC; Cohen, MS; Duker, JS; McNamara, JA; Sergott, RC, 1990) |
| "Twenty seven eyes treated for ischaemic central retinal vein occlusion with panretinal photocoagulation were reviewed." | 1.28 | Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation. ( Murdoch, IE; Rosen, PH; Shilling, JS, 1991) |
| "Vitreous hemorrhage was present in 75% of eyes immediately after surgery and cleared in an average of 6." | 1.27 | Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. ( Michels, RG; Oyakawa, RT; Rice, TA; Schachat, AP, 1983) |
| "Vitreous cavity hemorrhage is a frequent problem following diabetic vitrectomy, and can be managed by either vitreous cavity lavage or outpatient fluid-air exchange procedures." | 1.27 | Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy. ( Blankenship, GW, 1986) |
| "Karotype studies showed several chromosomal abnormalities following radiotherapy." | 1.27 | Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma. ( Albert, DM; Cassady, JR; Leombruno, D; Little, JB; Puliafito, CA; Trantravahi, R; Walton, DS; Weichselbaum, RR, 1986) |
| "Intraocular pressure was experimentally elevated by injecting fluid through a cannula into the anterior chamber, using a special Guyon syringe." | 1.27 | [Intraocular pulse fluctuations in pressure in neovascularization glaucoma in comparison to other forms of glaucoma (results of direct manometric measurements)]. ( Jaeger, W, 1986) |
| "The two types of central retinal vein occlusion, and suggestions for their management, are also discussed." | 1.27 | Central retinal vein occlusion and iris neovascularization hemorrhage. ( Lalle, PA; Myers, KJ, 1988) |
| "Intraocular pressure was reduced from a mean of 35." | 1.27 | [Retinal cryocoagulation in rubeosis iridis]. ( Schildwächter, A; Witschel, H, 1988) |
| "Sarcoidosis is a well-established cause of ocular neovascularization." | 1.27 | Proliferative sarcoid retinopathy. ( Brown, GC; Duker, JS; McNamara, JA, 1988) |
| "This synopsis is confined to pathological angiogenesis involving the retina, iris, and cornea." | 1.26 | Ocular angiogenesis in disease states. ( Garner, A; Kissun, RD, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 146 (37.92) | 18.7374 |
| 1990's | 101 (26.23) | 18.2507 |
| 2000's | 65 (16.88) | 29.6817 |
| 2010's | 66 (17.14) | 24.3611 |
| 2020's | 7 (1.82) | 2.80 |
| Authors | Studies |
|---|---|
| Sim, HE | 1 |
| Hwang, JH | 1 |
| Udyaver, S | 1 |
| Dalvin, LA | 1 |
| Lim, LS | 1 |
| Mazloumi, M | 1 |
| Atalay, HT | 1 |
| Khoo, CTL | 1 |
| Shields, JA | 4 |
| Shields, CL | 6 |
| Yeung, HH | 1 |
| Akagi, T | 1 |
| Fujimoto, M | 1 |
| Ikeda, HO | 1 |
| Handzel, DM | 1 |
| Alani, A | 1 |
| Handzel, RP | 1 |
| Ang, M | 1 |
| Devarajan, K | 1 |
| Tan, AC | 1 |
| Ke, M | 1 |
| Tan, B | 1 |
| Teo, K | 1 |
| Sng, CCA | 1 |
| Ting, DS | 1 |
| Schmetterer, L | 1 |
| Bas, Z | 1 |
| Yaghy, A | 1 |
| Ozawa, H | 1 |
| Usui, Y | 1 |
| Takano, Y | 1 |
| Horiuchi, N | 1 |
| Kuribayashi, T | 1 |
| Kurihara, T | 1 |
| Smith, LEH | 1 |
| Tsubota, K | 1 |
| Tomita, Y | 1 |
| McLeod, D | 1 |
| Roberts, PK | 1 |
| Goldstein, DA | 1 |
| Fawzi, AA | 1 |
| Beaujean, O | 2 |
| Locri, F | 3 |
| Aronsson, M | 3 |
| Kvanta, A | 3 |
| André, H | 3 |
| Ma, F | 1 |
| Su, J | 1 |
| Shang, Q | 1 |
| Ma, J | 1 |
| Zhang, T | 1 |
| Wang, X | 1 |
| Ma, H | 1 |
| Yu, J | 1 |
| Zett, C | 1 |
| Stina, DMR | 1 |
| Kato, RT | 1 |
| Novais, EA | 1 |
| Allemann, N | 1 |
| An, W | 1 |
| Zhang, Y | 1 |
| Zhang, X | 1 |
| Li, K | 1 |
| Kang, Y | 1 |
| Akhtar, S | 1 |
| Sha, X | 1 |
| Gao, L | 1 |
| Li, S | 1 |
| Li, L | 1 |
| Zhou, Q | 1 |
| Gao, H | 1 |
| Liu, M | 1 |
| Shi, W | 1 |
| Dal Monte, M | 1 |
| Cammalleri, M | 1 |
| De Rosa, M | 1 |
| Pavone, V | 1 |
| Bagnoli, P | 1 |
| Shiozaki, D | 1 |
| Sakimoto, S | 1 |
| Shiraki, A | 1 |
| Wakabayashi, T | 3 |
| Fukushima, Y | 1 |
| Oie, Y | 1 |
| Usui, S | 1 |
| Sato, S | 1 |
| Sakaguchi, H | 3 |
| Nishida, K | 2 |
| Călugăru, D | 1 |
| Călugăru, M | 1 |
| SooHoo, JR | 1 |
| Seibold, LK | 1 |
| Kahook, MY | 1 |
| Shiraya, T | 1 |
| Kato, S | 1 |
| Shigeeda, T | 1 |
| Katsuta, T | 1 |
| Fujimoto, A | 1 |
| Oba, K | 1 |
| Lüke, J | 2 |
| Nassar, K | 2 |
| Lüke, M | 2 |
| Grisanti, S | 3 |
| Shiba, C | 1 |
| Takahashi, M | 2 |
| Yoshida, I | 1 |
| Ubuka, M | 1 |
| Ashizawa, J | 1 |
| Shiba, T | 2 |
| Hori, Y | 2 |
| Sato, Y | 2 |
| Maeno, T | 2 |
| Gorovoy, IR | 1 |
| Vaccari, JC | 1 |
| Gandhi, JS | 1 |
| Md Noh, UK | 1 |
| Ahem, A | 1 |
| Mustapha, M | 1 |
| Modrzejewska, M | 1 |
| Kulik, U | 1 |
| Lubiński, W | 1 |
| Waisbourd, M | 1 |
| Shemesh, G | 1 |
| Kurtz, S | 1 |
| Rachmiel, R | 1 |
| Moisseiev, E | 1 |
| Zayit-Soudri, S | 1 |
| Loewenstein, A | 1 |
| Barequet, I | 1 |
| Rao, RC | 1 |
| Choudhry, N | 1 |
| Apte, RS | 1 |
| Parikh, R | 1 |
| Shah, RJ | 1 |
| VanHouten, JP | 1 |
| Cherney, EF | 1 |
| Noma, H | 1 |
| Mimura, T | 1 |
| Yasuda, K | 1 |
| Shimura, M | 1 |
| Mantel, I | 1 |
| Schalenbourg, A | 1 |
| Bergin, C | 1 |
| Petrovic, A | 1 |
| Weber, DC | 1 |
| Zografos, L | 1 |
| McAllister, IL | 1 |
| Tan, MH | 1 |
| Smithies, LA | 1 |
| Wong, WL | 1 |
| Hou, XR | 1 |
| Miao, H | 1 |
| Tao, Y | 3 |
| Li, XX | 1 |
| Wong, IY | 1 |
| Kim, JW | 1 |
| Ngai, LK | 1 |
| Sadda, S | 1 |
| Murakami, Y | 1 |
| Lee, DK | 1 |
| Murphree, AL | 1 |
| Edwards, TL | 1 |
| McKelvie, P | 1 |
| Walland, MJ | 1 |
| Arana, AM | 1 |
| Bierdeman, MA | 1 |
| Balzli, CL | 1 |
| Tang, A | 1 |
| Caballero, AR | 1 |
| Patel, R | 1 |
| O'Callaghan, RJ | 1 |
| Chew, MC | 1 |
| Tan, CS | 1 |
| Hariprasad, SM | 1 |
| Ishibashi, S | 2 |
| Kondo, H | 1 |
| Weng, SW | 1 |
| Huang, TL | 1 |
| Su, PY | 1 |
| Chang, PY | 1 |
| Wang, JK | 1 |
| Lee, AG | 1 |
| Smith, SV | 1 |
| Little, LM | 1 |
| Thrane, AS | 1 |
| Hove, M | 1 |
| Kjersem, B | 1 |
| Krohn, J | 1 |
| Jung, YH | 1 |
| Ahn, SJ | 1 |
| Hong, JH | 1 |
| Park, KH | 1 |
| Han, MK | 1 |
| Jung, C | 1 |
| Woo, SJ | 1 |
| Papastefanou, VP | 1 |
| Burris, CK | 1 |
| Sagoo, MS | 1 |
| Farahvash, MS | 1 |
| Farahvash, MM | 1 |
| Moradimogadam, M | 1 |
| Mohammadzadeh, S | 1 |
| Jiang, Y | 1 |
| Liang, X | 1 |
| Li, X | 1 |
| Wang, K | 1 |
| Demidenko, A | 1 |
| Jakobiec, FA | 1 |
| Hanna, E | 1 |
| Walton, DS | 2 |
| Duch, S | 1 |
| Buchacra, O | 1 |
| Milla, E | 1 |
| Andreu, D | 1 |
| Tellez, J | 1 |
| Fujioka, S | 1 |
| Karashima, K | 1 |
| Saito, Y | 1 |
| Lupinacci, AP | 1 |
| Calzada, JI | 1 |
| Rafieetery, M | 1 |
| Charles, S | 2 |
| Netland, PA | 1 |
| Jonas, JB | 4 |
| Libondi, T | 1 |
| Schlichtenbrede, F | 1 |
| Schmidbauer, M | 1 |
| Hosny, MH | 1 |
| Zayed, MA | 1 |
| Shalaby, AM | 1 |
| Eissa, IM | 1 |
| Batman, C | 1 |
| Ozdamar, Y | 1 |
| Chen, CH | 1 |
| Lai, IC | 1 |
| Wu, PC | 1 |
| Chen, YJ | 1 |
| Chen, YH | 1 |
| Lee, JJ | 1 |
| Liu, YC | 1 |
| Kuo, HK | 1 |
| Zarfoss, MK | 1 |
| Breaux, CB | 1 |
| Whiteley, HE | 1 |
| Hamor, RE | 1 |
| Flaws, JA | 1 |
| Labelle, P | 1 |
| Dubielzig, RR | 1 |
| Yeung, SN | 1 |
| Paton, KE | 1 |
| Waite, C | 1 |
| Maberley, DA | 1 |
| Sugimoto, Y | 1 |
| Mochizuki, H | 1 |
| Okumichi, H | 1 |
| Takumida, M | 1 |
| Takamatsu, M | 1 |
| Kawamata, S | 1 |
| Kiuchi, Y | 1 |
| Mulholland, CP | 1 |
| Rootman, J | 1 |
| Lyons, CJ | 1 |
| Scholl, S | 1 |
| Kirchhof, J | 1 |
| Augustin, AJ | 1 |
| Yuan, MK | 1 |
| Yu, WZ | 1 |
| Kai, W | 1 |
| Jiang, YR | 1 |
| Tawara, A | 2 |
| Sohma, R | 1 |
| Kubota, T | 2 |
| Toh, N | 1 |
| Patel, J | 1 |
| Turaka, K | 1 |
| Gulkilik, G | 1 |
| Erdenoz, S | 1 |
| Oba, EM | 1 |
| Sugiura, Y | 1 |
| Okamoto, F | 1 |
| Okamoto, Y | 1 |
| Hasegawa, Y | 1 |
| Hiraoka, T | 1 |
| Oshika, T | 1 |
| Saishin, Y | 1 |
| Verdaguer, P | 1 |
| Verdaguer Agustí, P | 1 |
| Nadal Reus, J | 1 |
| Kotecha, A | 1 |
| Spratt, A | 1 |
| Ogunbowale, L | 1 |
| dell'Omo, R | 2 |
| Kulkarni, A | 2 |
| Bunce, C | 1 |
| Franks, WA | 2 |
| Chan, CK | 1 |
| Ip, MS | 1 |
| Vanveldhuisen, PC | 1 |
| Oden, NL | 1 |
| Scott, IU | 2 |
| Tolentino, MJ | 4 |
| Blodi, BA | 1 |
| Paula, JS | 1 |
| Ribeiro, VR | 1 |
| Sampaio, RB | 1 |
| Mendonca, RJ | 1 |
| Haddad, A | 1 |
| Tedesco, AC | 1 |
| Coutinho-Netto, J | 1 |
| Haendchen, HA | 1 |
| Jorge, R | 2 |
| Sasamoto, Y | 1 |
| Oshima, Y | 3 |
| Miki, A | 2 |
| Song, D | 1 |
| Matsushita, K | 1 |
| Hamasaki, T | 1 |
| Browning, AC | 1 |
| Halligan, EP | 1 |
| Stewart, EA | 1 |
| Swan, DC | 1 |
| Dove, R | 1 |
| Samaranayake, GJ | 1 |
| Amoaku, WM | 1 |
| Faure, C | 1 |
| Miocque, S | 1 |
| Fleury, L | 1 |
| Robert, MP | 1 |
| Errera, MH | 1 |
| Egan, C | 1 |
| Deák, GG | 1 |
| Bolz, M | 1 |
| Prager, S | 1 |
| Ritter, M | 1 |
| Kriechbaum, K | 1 |
| Scholda, C | 1 |
| Schmidt-Erfurth, U | 1 |
| Salman, AG | 1 |
| Kapoor, KG | 1 |
| Baratz, KH | 1 |
| Barkmeier, AJ | 1 |
| Joshi, L | 1 |
| Tomkins-Netzer, O | 1 |
| Menezo, V | 1 |
| Sallam, A | 1 |
| Kirkpatrick, N | 1 |
| Lightman, S | 1 |
| Taylor, SR | 1 |
| Ababneh, OH | 1 |
| Yousef, YA | 1 |
| Gharaibeh, AM | 1 |
| Abu Ameerh, MA | 1 |
| Abu-Yaghi, NE | 1 |
| Al Bdour, MD | 1 |
| Söfker, A | 2 |
| Boyd, SR | 2 |
| Zachary, I | 1 |
| Chakravarthy, U | 1 |
| Allen, GJ | 1 |
| Wisdom, GB | 1 |
| Cree, IA | 2 |
| Martin, JF | 1 |
| Hykin, PG | 2 |
| Genaidy, M | 1 |
| Kazi, AA | 1 |
| Peyman, GA | 2 |
| Passos-Machado, E | 1 |
| Farahat, HG | 1 |
| Williams, JI | 1 |
| Holroyd, KJ | 1 |
| Blake, DA | 1 |
| Fuller, JJ | 2 |
| Mason, JO | 3 |
| White, MF | 2 |
| McGwin, G | 2 |
| Emond, TL | 2 |
| Feist, RM | 2 |
| Lang, GE | 4 |
| Kreissig, I | 2 |
| Degenring, RF | 1 |
| La Heij, EC | 1 |
| Tecim, S | 1 |
| Kessels, AG | 1 |
| Liem, AT | 1 |
| Japing, WJ | 1 |
| Hendrikse, F | 1 |
| Cursiefen, C | 1 |
| Masli, S | 1 |
| Ng, TF | 1 |
| Dana, MR | 1 |
| Bornstein, P | 1 |
| Lawler, J | 1 |
| Streilein, JW | 1 |
| Parodi, MB | 3 |
| Iacono, P | 2 |
| Laatikainen, L | 1 |
| Puusaari, I | 1 |
| Heikkonen, J | 1 |
| Kivelä, T | 1 |
| Itakura, H | 1 |
| Kishi, S | 2 |
| Kotajima, N | 1 |
| Murakami, M | 1 |
| Menchini, U | 1 |
| Cappelli, S | 1 |
| Virgili, G | 1 |
| Green, WR | 4 |
| Chan, CC | 3 |
| Hutchins, GM | 1 |
| Terry, JM | 1 |
| Bhisitkul, RB | 1 |
| Robinson, GS | 1 |
| Moulton, RS | 2 |
| Claffey, KP | 1 |
| Gragoudas, ES | 4 |
| Miller, JW | 8 |
| Detorakis, ET | 1 |
| Engstrom, RE | 1 |
| Wallace, R | 1 |
| Straatsma, BR | 1 |
| Schäfer, S | 1 |
| Ruprecht, KW | 1 |
| Colagross, CT | 1 |
| Haleman, T | 1 |
| Gittos, A | 1 |
| Richter, M | 1 |
| Hungerford, JL | 2 |
| Errington, RD | 2 |
| Avery, RL | 3 |
| Patel, H | 1 |
| Patel, DV | 1 |
| Brookes, NH | 1 |
| McGhee, CN | 1 |
| Ramezani, A | 1 |
| Entezari, M | 1 |
| Moradian, S | 1 |
| Tabatabaei, H | 1 |
| Kadkhodaei, S | 1 |
| Kuroda, T | 1 |
| Katai, N | 1 |
| Yoshida, N | 1 |
| Murata, T | 1 |
| Krzystolik, MG | 1 |
| Filippopoulos, T | 1 |
| Ducharme, JF | 1 |
| Loewenstein, JI | 1 |
| Gomi, F | 2 |
| Tano, Y | 2 |
| Biester, S | 1 |
| Peters, S | 1 |
| Tatar, O | 1 |
| Ziemssen, F | 1 |
| Bartz-Schmidt, KU | 1 |
| Silva Paula, J | 1 |
| Alves Costa, R | 1 |
| Rodrigues, Mde L | 1 |
| Sun, H | 1 |
| Manquez, ME | 1 |
| Leahey, A | 1 |
| Meadows, AT | 1 |
| Albert, MA | 1 |
| Mays, A | 1 |
| Vail, R | 1 |
| Telander, DG | 1 |
| Holland, GN | 1 |
| Wax, MB | 1 |
| Van Gelder, RN | 1 |
| Pearlman, J | 1 |
| Pieramici, DJ | 1 |
| Rabena, MD | 1 |
| Castellarin, AA | 1 |
| Nasir, MA | 1 |
| Giust, MJ | 1 |
| Wendel, R | 1 |
| Patel, A | 1 |
| Chen, SD | 1 |
| Chen, FK | 1 |
| Patel, C | 1 |
| Dorrell, M | 1 |
| Uusitalo-Jarvinen, H | 1 |
| Aguilar, E | 1 |
| Friedlander, M | 1 |
| Madhusudhana, KC | 1 |
| Newsom, RS | 1 |
| Eren, E | 1 |
| Küçükerdönmez, C | 1 |
| Yilmaz, G | 1 |
| Akova, YA | 1 |
| Mennel, S | 1 |
| Barbazetto, I | 1 |
| Meyer, CH | 1 |
| Peter, S | 1 |
| Stur, M | 1 |
| Amselem, L | 1 |
| Montero, J | 1 |
| Diaz-Llopis, M | 1 |
| Pulido, JS | 1 |
| Bakri, SJ | 1 |
| Palomares, P | 1 |
| Garcia-Delpech, S | 1 |
| Batioğlu, F | 1 |
| Astam, N | 1 |
| Ozmert, E | 1 |
| Chilov, MN | 1 |
| Grigg, JR | 1 |
| Playfair, TJ | 1 |
| Ichhpujani, P | 1 |
| Ramasubramanian, A | 1 |
| Kaushik, S | 1 |
| Pandav, SS | 1 |
| Avery, RB | 1 |
| Diener-West, M | 1 |
| Reynolds, SM | 1 |
| Grossniklaus, HE | 1 |
| Albert, DM | 2 |
| Ravalico, G | 2 |
| Ikuno, Y | 1 |
| Otori, Y | 1 |
| Kamei, M | 1 |
| Kusaka, S | 1 |
| Harris, M | 1 |
| Tso, AY | 1 |
| Kaba, FW | 1 |
| de la Cruz, ZC | 1 |
| Sanborn, GE | 2 |
| Magargal, LE | 6 |
| Lodato, G | 1 |
| Brancato, G | 1 |
| Garner, A | 3 |
| Hung, JY | 1 |
| Hilton, GF | 1 |
| Garcia, CA | 1 |
| Ruiz, RS | 1 |
| Federman, JL | 2 |
| Brown, GC | 13 |
| Felberg, NT | 2 |
| Felton, SM | 2 |
| Schwartz, LW | 1 |
| Spaeth, GL | 2 |
| Kornacki, B | 1 |
| Lee, PF | 2 |
| Shihab, ZM | 1 |
| Fu, YA | 1 |
| Tasman, W | 1 |
| Augsburger, JJ | 3 |
| Kluxen, G | 2 |
| Friedburg, D | 1 |
| Ruppert, A | 1 |
| Kottow, MH | 1 |
| Alpar, JJ | 1 |
| Raitta, C | 1 |
| Ringvold, A | 1 |
| Davanger, M | 1 |
| Mason, G | 1 |
| Detry-Morel, M | 1 |
| Ryan, SJ | 1 |
| Welch, RB | 1 |
| Kissun, RD | 1 |
| Blodi, FC | 1 |
| Ririe, DG | 1 |
| Riekhof, FT | 1 |
| Buchanan, TA | 1 |
| Hoyt, WF | 1 |
| Parrish, RK | 1 |
| Teich, SA | 1 |
| Walsh, JB | 1 |
| Virdi, PS | 2 |
| Hayreh, SS | 8 |
| Baurmann, H | 1 |
| Chioralia, G | 1 |
| Siefert, H | 1 |
| Jensen, HM | 1 |
| Chen, I | 1 |
| DeVault, MR | 1 |
| Lewis, AE | 1 |
| Shlopak, TV | 1 |
| Bondareva, GS | 1 |
| Jones, WL | 2 |
| Rice, TA | 7 |
| Michels, RG | 8 |
| Maguire, MG | 1 |
| Rice, EF | 4 |
| Brooks, AM | 7 |
| Gillies, WE | 8 |
| Nomura, T | 2 |
| Furukawa, H | 1 |
| Kurimoto, S | 1 |
| Detry, M | 1 |
| Waterschoot, MP | 1 |
| Kevers, L | 1 |
| Michiels, J | 1 |
| Demeler, U | 2 |
| L'Esperance, FA | 2 |
| Mittl, RN | 2 |
| Bonnet, M | 4 |
| El Khatib, W | 1 |
| Schachat, AP | 1 |
| Oyakawa, RT | 1 |
| Rojas, P | 1 |
| Podhajsky, P | 2 |
| Montague, P | 1 |
| Woolson, RF | 1 |
| Mayer, J | 1 |
| Brouillette, G | 2 |
| Corriveau, LA | 1 |
| Maltzman, BA | 1 |
| Constad, WH | 1 |
| Caputo, AR | 1 |
| John, T | 1 |
| Sassani, JW | 1 |
| Eagle, RC | 2 |
| Aiello, LM | 1 |
| Wand, M | 1 |
| Liang, G | 1 |
| James, WA | 1 |
| Roeseler, K | 1 |
| Buhr-Unger, H | 1 |
| Molteno, AC | 2 |
| Cowan, CL | 1 |
| Butler, G | 1 |
| Archer, DB | 1 |
| Stefansson, E | 1 |
| Landers, MB | 2 |
| Wolbarsht, ML | 1 |
| Klintworth, GK | 2 |
| Hauch, TL | 1 |
| Busuttil, RW | 1 |
| Yoshizumi, MO | 2 |
| Okada, H | 1 |
| Sano, T | 1 |
| Yoneda, M | 1 |
| Miki, H | 5 |
| Williams, GA | 1 |
| Eisenstein, R | 1 |
| Schumacher, B | 1 |
| Hsiao, KC | 1 |
| Grant, D | 1 |
| Cassel, GH | 1 |
| Groden, LR | 1 |
| Schachat, A | 1 |
| Shah, H | 1 |
| Ehrenberg, M | 1 |
| McCuen, BW | 1 |
| Schindler, RH | 1 |
| Machemer, R | 1 |
| Apple, DJ | 1 |
| Craythorn, JM | 1 |
| Olson, RJ | 1 |
| Little, LE | 1 |
| Lyman, JB | 1 |
| Reidy, JJ | 1 |
| Loftfield, K | 1 |
| Moffat, K | 1 |
| Blumenkranz, MS | 2 |
| Hernandez, E | 1 |
| Packer, AJ | 3 |
| Tse, DT | 1 |
| Gu, XQ | 3 |
| Belcher, CD | 2 |
| Simmons, RJ | 3 |
| Thomas, JV | 3 |
| Higgins, RA | 1 |
| Chodak, GW | 1 |
| Summerhayes, I | 1 |
| Mensher, JH | 1 |
| Striga, M | 1 |
| Ivanisević, M | 1 |
| Sandramouli, S | 3 |
| Sihota, R | 3 |
| Sood, NN | 3 |
| Heegaard, S | 1 |
| Harino, S | 1 |
| Motokura, M | 1 |
| Nishikawa, N | 1 |
| Fukuda, M | 1 |
| Sasaoka, A | 1 |
| Grunwald, JE | 1 |
| Jaffery, N | 1 |
| Sandberg, MA | 1 |
| Gaudio, AR | 1 |
| Miller, S | 1 |
| Weiner, A | 1 |
| Stirpe, M | 1 |
| Bucci, MG | 1 |
| Quaranta, L | 1 |
| Daftari, TK | 1 |
| Whitesides, TE | 1 |
| Heller, JG | 1 |
| Goodrich, AC | 1 |
| McCarey, BE | 1 |
| Hutton, WC | 1 |
| Williamson, TH | 5 |
| Baxter, GM | 1 |
| Adamis, AP | 6 |
| Shima, DT | 3 |
| D'Amore, PA | 3 |
| O'Reilly, MS | 2 |
| Folkman, J | 3 |
| Dvorak, HF | 1 |
| Brown, LF | 1 |
| Berse, B | 1 |
| Severns, ML | 2 |
| Johnson, MA | 5 |
| Meyer-Schwickerath, R | 2 |
| Hagel, A | 1 |
| Nahberger, D | 2 |
| Gronemeyer, U | 2 |
| Bandello, F | 1 |
| Brancato, R | 2 |
| Lattanzio, R | 1 |
| Carnevalini, A | 1 |
| Rossi, A | 1 |
| Coscas, G | 1 |
| Clarkson, JG | 1 |
| Stefaniotou, M | 1 |
| Paschides, CA | 1 |
| Psilas, K | 1 |
| Maruyama, Y | 1 |
| Kamei, Y | 1 |
| Shimizu, R | 1 |
| Kimura, Y | 1 |
| Blinder, KJ | 1 |
| Friedman, SM | 1 |
| Mames, RN | 1 |
| Asrani, S | 1 |
| Zeimer, R | 1 |
| Küchle, M | 2 |
| Vinores, SA | 1 |
| Stinson, WG | 2 |
| Ulbig, MR | 1 |
| Foss, AJ | 2 |
| Schwartz, SD | 1 |
| Hamilton, PA | 1 |
| McPhee, TJ | 2 |
| Duker, JS | 6 |
| Lehman, R | 1 |
| Azzolini, C | 1 |
| Camesasca, FI | 1 |
| Codenotti, M | 1 |
| Nishikawa, M | 4 |
| Ito, S | 4 |
| Tokura, T | 4 |
| Keenan, JM | 1 |
| Dodson, PM | 2 |
| Kritzinger, EE | 2 |
| Ferrara, N | 2 |
| Ramsay, A | 1 |
| Parks, S | 1 |
| Keating, D | 2 |
| Hood, DC | 1 |
| Gougos, A | 1 |
| Tolentino, M | 1 |
| Robinson, G | 1 |
| Chatzistefanou, K | 1 |
| Bondel, E | 1 |
| Russo, D | 1 |
| Rumley, A | 1 |
| Lowe, GD | 1 |
| Gaspar, AZ | 1 |
| Flammer, J | 1 |
| Hendrickson, P | 1 |
| van Meurs, JC | 1 |
| Bolt, BJ | 1 |
| Mertens, DA | 1 |
| Peperkamp, E | 1 |
| De Waard, P | 1 |
| Uram, M | 1 |
| Bradnam, M | 1 |
| Fernández-Vigo, J | 1 |
| Castro, J | 1 |
| Macarro, A | 1 |
| Bourke, RD | 1 |
| Cooling, RJ | 1 |
| Pe'er, J | 1 |
| Neufeld, M | 1 |
| Baras, M | 1 |
| Gnessin, H | 1 |
| Itin, A | 1 |
| Keshet, E | 1 |
| Husain, D | 1 |
| Kenney, AG | 1 |
| Michaud, N | 1 |
| Flotte, TJ | 1 |
| Flaxel, CJ | 1 |
| Larkin, GB | 1 |
| Broadway, DB | 1 |
| Allen, PJ | 1 |
| Leaver, PK | 1 |
| Singh, K | 1 |
| Eid, TE | 1 |
| Katz, LJ | 1 |
| Whelehan, I | 1 |
| Anderson, DF | 1 |
| Kacperek, A | 1 |
| Restori, M | 1 |
| Kongerud, J | 1 |
| Sheen, M | 1 |
| Ino-ue, M | 1 |
| Azumi, A | 1 |
| Shirabe, H | 1 |
| Yamamoto, M | 1 |
| Händel, A | 1 |
| Naumann, GO | 1 |
| Tripathi, RC | 1 |
| Li, J | 2 |
| Tripathi, BJ | 1 |
| Chalam, KV | 1 |
| Browning, DJ | 2 |
| Scott, AQ | 1 |
| Peterson, CB | 1 |
| Warnock, J | 1 |
| Zhang, Z | 1 |
| Luttrull, JK | 1 |
| Barile, GR | 1 |
| Chang, S | 2 |
| Horowitz, JD | 1 |
| Reppucci, VS | 1 |
| Schiff, WM | 1 |
| Wong, DT | 1 |
| Greven, CM | 1 |
| Hackel, RE | 1 |
| Slusher, MM | 1 |
| Helbig, H | 1 |
| Kellner, U | 1 |
| Bornfeld, N | 1 |
| Foerster, MH | 1 |
| Shah, GK | 1 |
| Sharma, S | 1 |
| Ishida, M | 1 |
| Ikeda, T | 1 |
| Sawa, H | 1 |
| Koizumi, K | 1 |
| Maeda, K | 1 |
| Terasaki, H | 1 |
| Miyake, Y | 1 |
| Mori, M | 1 |
| Suzuki, T | 1 |
| Kondo, M | 1 |
| Chen, KH | 1 |
| Wu, CC | 1 |
| Roy, S | 1 |
| Lee, SM | 1 |
| Liu, JH | 1 |
| Wiechens, B | 1 |
| Nölle, B | 1 |
| Hamard, P | 1 |
| Baudouin, C | 1 |
| Larsson, J | 2 |
| Bauer, B | 1 |
| Andréasson, S | 2 |
| Saygili, O | 1 |
| Duh, EJ | 1 |
| Finkelstein, D | 1 |
| Schneider, T | 1 |
| Malouf, A | 1 |
| Kaplan, G | 1 |
| Costa, JR | 1 |
| Krause, M | 1 |
| Friedman, E | 1 |
| D'Amico, DJ | 1 |
| Hayler, JK | 1 |
| Panda-Jonas, S | 1 |
| Tsaloumas, MD | 1 |
| Kirwan, J | 1 |
| Vinall, H | 1 |
| O'Leary, MB | 1 |
| Prior, P | 1 |
| Hamanaka, T | 1 |
| Akabane, N | 1 |
| Yajima, T | 1 |
| Takahashi, T | 1 |
| Tanabe, A | 1 |
| Witmer, AN | 1 |
| van Blijswijk, BC | 1 |
| Dai, J | 1 |
| Hofman, P | 1 |
| Partanen, TA | 1 |
| Vrensen, GF | 1 |
| Schlingemann, RO | 1 |
| Chao, AN | 1 |
| Krema, H | 1 |
| Hata, Y | 1 |
| Sakamoto, T | 1 |
| Honda, M | 1 |
| Yoshikawa, H | 1 |
| Inomata, H | 1 |
| Ohnishi, Y | 1 |
| Lai, YK | 1 |
| Shen, WY | 1 |
| Brankov, M | 1 |
| Lai, CM | 1 |
| Constable, IJ | 1 |
| Rakoczy, PE | 1 |
| Grignolo, FM | 1 |
| Musso, M | 1 |
| Borromeo, P | 1 |
| Sebastiani, F | 1 |
| von Denffer, H | 1 |
| Erhardt, W | 1 |
| Neiss, A | 1 |
| Mason, GI | 1 |
| Grange, JD | 3 |
| Algvere, P | 1 |
| Young, NJ | 1 |
| Hitchings, RA | 1 |
| Sehmi, K | 1 |
| Bird, AC | 1 |
| Little, HL | 2 |
| Pingault, C | 1 |
| Jacobson, DR | 1 |
| Murphy, RP | 1 |
| Rosenthal, AR | 1 |
| Lim, JI | 1 |
| Bressler, NM | 1 |
| Rehák, J | 3 |
| Bopp, S | 1 |
| Lucke, K | 1 |
| Laqua, H | 1 |
| Wakelee-Lynch, J | 1 |
| Hjelmeland, LM | 1 |
| Stewart, MW | 1 |
| Toth, CA | 1 |
| Burns, MS | 1 |
| Yamane, A | 3 |
| Comaratta, MR | 1 |
| Sparrow, J | 1 |
| Klemperer, I | 1 |
| Yassur, Y | 1 |
| David, R | 1 |
| Brandt, F | 1 |
| Zhou, HM | 1 |
| Shi, ZR | 1 |
| Rai, N | 1 |
| Thuladar, L | 1 |
| Pradhan, H | 1 |
| Vander, JF | 1 |
| Benson, WE | 2 |
| Sivalingam, A | 2 |
| Kenney, J | 1 |
| Donoso, L | 1 |
| Prasad, P | 1 |
| Setna, PH | 1 |
| Dunne, JA | 1 |
| Klugman, MR | 1 |
| Servais, GE | 1 |
| Perkins, ES | 1 |
| Cohen, MS | 1 |
| Sergott, RC | 1 |
| McNamara, JA | 2 |
| Eifrig, DE | 1 |
| Hermsen, V | 1 |
| McManus, P | 1 |
| Cunningham, R | 1 |
| Reber, R | 1 |
| Barke, RM | 1 |
| Hepler, RS | 1 |
| Krauss, HR | 1 |
| Jabour, BA | 1 |
| Rohrbach, JM | 1 |
| Steuhl, KP | 1 |
| Thiel, HJ | 1 |
| Capone, A | 1 |
| Meredith, TA | 1 |
| Medlock, RD | 1 |
| Yarian, DL | 1 |
| Beyrer, CR | 1 |
| Ko, MK | 1 |
| Park, IW | 1 |
| Kim, YJ | 1 |
| Choe, JK | 1 |
| Matsui, M | 1 |
| Murdoch, IE | 1 |
| Rosen, PH | 1 |
| Shilling, JS | 1 |
| Tanaka, S | 1 |
| Ideta, H | 1 |
| Yonemoto, J | 1 |
| Sasaki, K | 1 |
| Hirose, A | 1 |
| Oka, C | 1 |
| Breton, ME | 2 |
| Schueller, AW | 1 |
| Montzka, DP | 1 |
| Gregory, WA | 1 |
| el-Koumy, HA | 1 |
| Puliafito, CA | 2 |
| Kecik, T | 1 |
| Ciszewska, J | 1 |
| Yamaaki, H | 1 |
| Tso, MO | 2 |
| Goldberg, MF | 1 |
| Sugar, J | 1 |
| Stefani, FH | 1 |
| Sellem, EA | 1 |
| Belcher, DC | 1 |
| Perkins, SA | 1 |
| Blankenship, GW | 1 |
| Symes, DJ | 1 |
| Gerke, E | 2 |
| Alvira, G | 1 |
| Haddad, PJ | 1 |
| Tangas, C | 1 |
| Weichselbaum, RR | 1 |
| Cassady, JR | 1 |
| Little, JB | 1 |
| Leombruno, D | 1 |
| Trantravahi, R | 1 |
| Hutchins, RK | 1 |
| Gittinger, JW | 1 |
| Weiter, JJ | 1 |
| Weinreb, RN | 2 |
| Wasserstrom, JP | 1 |
| Parker, W | 1 |
| Servais, EG | 2 |
| Raichand, M | 1 |
| Juarez, CP | 1 |
| Reinglass, S | 1 |
| John, E | 1 |
| Jaeger, W | 1 |
| Terry, JE | 1 |
| Roberts, DK | 1 |
| Welge-Lüssen, L | 1 |
| Stadler, G | 1 |
| Effron, L | 1 |
| Zakov, ZN | 1 |
| Tomsak, RL | 1 |
| Thompson, JT | 2 |
| de Bustros, S | 2 |
| Pavese, T | 1 |
| Insler, MS | 1 |
| Pauleikhoff, D | 1 |
| Gabel, VP | 1 |
| Kampik, A | 1 |
| Gabel, C | 1 |
| Spiegel, D | 1 |
| Etre, JM | 1 |
| Magnus, DE | 1 |
| Brodell, LP | 1 |
| Olk, RJ | 1 |
| Arribas, NP | 1 |
| Okun, E | 1 |
| Johnston, GP | 1 |
| Boniuk, I | 1 |
| Escoffery, RF | 1 |
| Grand, MG | 1 |
| Burgess, DB | 1 |
| Schoch, LH | 1 |
| Burger, PC | 1 |
| Chandler, DB | 1 |
| Fryczkowski, AW | 2 |
| Irvine, AR | 1 |
| Wood, IS | 1 |
| Grant, G | 1 |
| Robertson, IF | 1 |
| Tauber, J | 1 |
| Lahav, M | 1 |
| Erzurum, SA | 1 |
| Melamed, S | 1 |
| Irvine, J | 1 |
| Lee, DA | 1 |
| Chebil, A | 1 |
| Boguszaková, J | 1 |
| Dubská, Z | 1 |
| Yeo, JH | 1 |
| Glaser, BM | 1 |
| Bresnick, GH | 1 |
| Marcus, S | 1 |
| Elman, MJ | 1 |
| Kaye, SB | 1 |
| Harding, SP | 1 |
| Vernon, SA | 1 |
| Cheng, H | 1 |
| Trempe, CL | 1 |
| Myers, KJ | 1 |
| Lalle, PA | 1 |
| Schildwächter, A | 1 |
| Witschel, H | 1 |
| Rogers, PA | 1 |
| Macpherson, AM | 1 |
| Beaton, LA | 1 |
| Oldendoerp, J | 2 |
| Spitznas, M | 2 |
| Nork, TM | 1 |
| Duvall, J | 1 |
| Heimann, K | 1 |
| Dahl, B | 1 |
| Dimopoulos, S | 1 |
| Lemmen, KD | 1 |
| Brourman, ND | 1 |
| Cox, MS | 1 |
| Trese, MT | 1 |
| Ehud, A | 1 |
| Varda, C | 1 |
| Joseph, M | 1 |
| Giora, T | 1 |
| Quinn, GE | 1 |
| Keene, SS | 1 |
| Dahmen, JC | 1 |
| Brucker, AJ | 1 |
| Zenker, HJ | 1 |
| Beer, EM | 1 |
| Karhan, J | 1 |
| Smecka, Z | 1 |
| Smecková, M | 1 |
| Chagnon, A | 1 |
| Payan, J | 1 |
| Levy, C | 1 |
| Chassain, C | 1 |
| Hodes, BL | 1 |
| Walker, J | 1 |
| Savage, JA | 1 |
| Fry, GL | 1 |
| Lata, GF | 1 |
| Hoak, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT02647515] | Phase 4 | 18 participants (Actual) | Interventional | 2013-01-31 | Completed | ||
| An Open Label, Prospective, Monocenter, Prove of Concept Study to Evaluate the Short- and Long-term Effects of 0.5mg Intraocular Ranibizumab (Lucentis) Injections as Adjuvant for Patients With Rubeosis and Neovascular Glaucoma[NCT01370135] | 20 participants (Actual) | Interventional | 2008-11-30 | Completed | |||
| The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study: Two Randomized Trials to Compare the Efficacy and Safety of Intravitreal Injection(s) of Triamcinolone Acetonide With Standard Care to Treat Macular Edema[NCT00105027] | Phase 3 | 682 participants (Actual) | Interventional | 2004-10-31 | Completed | ||
| Morphological and Functional Retinal Changes Following Retinal Photocoagulation Using a Semiautomated Patterned Scanning Laser System in Proliferative Retinopathy or Macular Edema Secondary to Diabetes Mellitus or Retinal Vein Occlusion[NCT00682240] | Phase 4 | 64 participants (Actual) | Interventional | 2007-10-31 | Completed | ||
| A Phase IV Open Label Trial of the Safety, Tolerability and Efficacy of 0.5mg Ranibizumab Intravitreal Injections Combined With Wide Field Angiography Guided Panretinal Photocoagulation vs. 0.5mg Ranibizumab Intravitreal Injection Monotherapy in Subjects [NCT01710839] | Phase 4 | 30 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
| Pilot Study for the Detection of Neutralizing Antibodies in Patients Treated With Bevacizumab Avastin or Ranibizumab Lucentis[NCT00605943] | 30 participants | Observational | 2008-01-16 | Completed | |||
| Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous and Subretinal Fluid in Patients With Retinopathy of Prematurity Stage V.[NCT00500396] | Phase 4 | 15 participants (Anticipated) | Interventional | 2007-03-31 | Completed | ||
| Vascular Endothelial Growth Factor Levels in Aqueous, Vitreous and Subretinal Fluid in Patients With Retinopathy of Prematurity Stage IV and V[NCT00563121] | Phase 4 | 16 participants (Actual) | Interventional | 2007-03-31 | Completed | ||
| Intravitreal Bevacizumab Vs Panretinal Photocoagulation for the Treatment of Proliferative Diabetic Retinopathy: A One-Year Prospective, Contralateral Eye Study[NCT00347698] | Phase 2/Phase 3 | 30 participants | Interventional | 2006-03-31 | Recruiting | ||
| A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy[NCT00618644] | 0 participants (Actual) | Interventional | 2010-01-31 | Withdrawn (stopped due to Withdrawn due to lack of eligible participants) | |||
| Evaluation of the Effect of Repeated Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using Optical Coherence Tomography Angiography[NCT03246152] | Phase 4 | 31 participants (Actual) | Interventional | 2017-10-23 | Completed | ||
| Randomized Controlled Trial of Lucentis in the Management of New Onset Neovascular Glaucoma[NCT00727038] | Phase 1/Phase 2 | 0 participants (Actual) | Interventional | 2008-01-04 | Withdrawn (stopped due to Company withdrew funding/sponsorship) | ||
| Vascular Endothelial Growth Factor (VEGF)Blockade With Intravitreal Pegaptnib in Non-Infectious Uveitic Cystoid Macular Edema (CME)[NCT00790803] | 5 participants (Actual) | Interventional | 2009-03-31 | Completed | |||
| Histologic Changes of Fibrovascular Membrane Associated With Proliferative Diabetic Retinopathy After Intravitreal Bevacizumab (Avastin®)[NCT00423059] | 20 participants | Interventional | 2006-12-31 | Completed | |||
| Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment[NCT00548197] | Phase 1 | 40 participants (Actual) | Interventional | 2007-02-28 | Completed | ||
| Subconjunctival Bevacizumab Injection for the Prevention of Bleb Vascularization Post Trabeculectomy[NCT00854529] | Phase 2 | 60 participants (Anticipated) | Interventional | 2009-04-30 | Not yet recruiting | ||
| [NCT00000131] | Phase 3 | 0 participants | Interventional | 1988-08-31 | Completed | ||
| The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study[NCT00106132] | Phase 3 | 1,260 participants | Interventional | 2005-03-31 | Completed | ||
| Ultra-wide Fluorescein angiograpHy to Evaluate the Progression of Retinal ischeMia After aflibErcept Injections in patientS With Central Retinal Vein Occlusion in Real Life (HERMES Study)[NCT02880644] | 65 participants (Actual) | Observational [Patient Registry] | 2017-01-26 | Completed | |||
| Correlation Between the Visual Acuity and the OCT Pattern of Macular Edema Secondary to Retinal Vein Occlusion[NCT03489915] | 30 participants (Anticipated) | Observational | 2018-05-01 | Not yet recruiting | |||
| Uncovering Inflammatory Mediators of Glaucoma Pathogenesis After Corneal Transplantation in Aqueous Humor and Tears[NCT04339907] | 200 participants (Anticipated) | Interventional | 2020-05-11 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00105027)
Timeframe: 12 months
| Intervention | letters read (Mean) |
|---|---|
| CRVO Observation | -12.1 |
| CRVO 1 mg Dose Triamcinolone Acetonide | -1.2 |
| CRVO 4 mg Dose Triamcinolone Acetonide | -1.2 |
| BRVO Standard Care | 4.2 |
| BRVO 1 mg Dose Triamcinolone Acetonide | 5.7 |
| BRVO 4 mg Dose Triamcinolone Acetonide | 4.0 |
(NCT00105027)
Timeframe: 12 months
| Intervention | um (Median) |
|---|---|
| CRVO Observation | -277 |
| CRVO 1 mg Dose Triamcinolone Acetonide | -196 |
| CRVO 4 mg Dose Triamcinolone Acetonide | -261 |
| BRVO Standard Care | -224 |
| BRVO 1 mg Dose Triamcinolone Acetonide | -149 |
| BRVO 4 mg Dose Triamcinolone Acetonide | -170 |
Visual acuity testing was done using electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) visual acuity testing at 3 meters using the Electronic Visual Acuity Tester by a SCORE certified technician. A masked visual acuity examiner with no knowledge of treatment assignments performed visual acuity testing at the 4-month, 12-month, 24-month and 36-month visits. An E-ETDRS visual acuity score of 85 is approximately 20/20, and a score of 20 letters is approximately 20/400. A visual acuity letter score change of 15 is about three lines on a vision chart. (NCT00105027)
Timeframe: Change from baseline to 12 months
| Intervention | Participants (Number) |
|---|---|
| CRVO Observation | 5 |
| CRVO 1 mg Dose Triamcinolone Acetonide | 22 |
| CRVO 4 mg Dose Triamcinolone Acetonide | 21 |
| BRVO Standard Care | 35 |
| BRVO 1 mg Dose Triamcinolone Acetonide | 31 |
| BRVO 4 mg Dose Triamcinolone Acetonide | 34 |
(NCT00105027)
Timeframe: 12 months
| Intervention | events (Number) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiation of IOP-lowering medications | IOP > 35 mm HG | IOP > 10 mm HG above baseline | Laser peripheral iridotomy | Trabeculectomy | Tube shunt | Cataract: lens opacity onset or progression | Cataract surgery | Infectious endophthalmitis | Noninfectious endophthalmitis | Retinal detachment | Iris neovascularization | Retinal neovascularization | Vitreous hemorrhage | YAG capsulotomy | Sector or panretinal photocagulation | Pars plana vitrectomy | |
| BRVO 1 mg Dose Triamcinolone Acetonide | 11 | 2 | 12 | 0 | 0 | 0 | 27 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 |
| BRVO 4 mg Dose Triamcinolone Acetonide | 57 | 14 | 50 | 1 | 0 | 0 | 38 | 4 | 1 | 0 | 0 | 2 | 3 | 3 | 1 | 4 | 1 |
| BRVO Standard Care | 3 | 1 | 1 | 0 | 0 | 0 | 15 | 3 | 0 | 0 | 1 | 1 | 5 | 2 | 1 | 5 | 1 |
| CRVO 1 mg Dose Triamcinolone Acetonide | 18 | 5 | 15 | 0 | 0 | 2 | 20 | 0 | 0 | 0 | 0 | 9 | 2 | 4 | 0 | 9 | 2 |
| CRVO 4 mg Dose Triamcinolone Acetonide | 32 | 8 | 24 | 1 | 0 | 0 | 25 | 4 | 0 | 0 | 0 | 4 | 2 | 0 | 0 | 3 | 0 |
| CRVO Observation | 7 | 1 | 2 | 0 | 0 | 0 | 12 | 0 | 0 | 0 | 0 | 2 | 4 | 4 | 1 | 5 | 1 |
Mean change in Central Foveal Volume on High Resolution OCT. (NCT01710839)
Timeframe: 12 months
| Intervention | cubic millimeters (Mean) |
|---|---|
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | -0.15 |
| Ranibizumab 0.5mg | -0.15 |
Percent of patients that develop neovascularization of the iris, optic nerve and/or elsewhere. (NCT01710839)
Timeframe: 12 months
| Intervention | percentage of patients (Number) |
|---|---|
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | 8.33 |
| Ranibizumab 0.5mg | 0 |
Assess the number of intravitreal injections over 12 months. (NCT01710839)
Timeframe: 12 months
| Intervention | injections (Mean) |
|---|---|
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | 8.7 |
| Ranibizumab 0.5mg | 9.5 |
Evaluate the mean change from baseline in ETDRS best-corrected visual acuity at 12 months. The ETDRS protocol is a widely accepted international standard for macular laser photocoagulation treatment. A higher score represents better functioning. (NCT01710839)
Timeframe: 12 month period
| Intervention | ETDRS BCVA Letters (Mean) |
|---|---|
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | 14.9 |
| Ranibizumab 0.5mg | 10.7 |
Incidence and severity of adverse events (ocular and non-ocular). (NCT01710839)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Notable Ocular Events | Serious Non-Ocular Events | |
| Ranibizumab 0.5mg | 2 | 0 |
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | 17 | 2 |
Goldman Visual Field changes at 6 and 12 months from baseline. Goldmann perimetry is a method used to map a patient's field of vision (central and peripheral). Changes will be assessed by manual digital quantification of GVF plots. (NCT01710839)
Timeframe: 6 and 12 Months
| Intervention | square degrees (Mean) | |
|---|---|---|
| Month 6 | Month 12 | |
| Ranibizumab 0.5mg | 102 | -1875 |
| Targeted Pan Retinal Laser Combined With 0.5mg Ranibizumab | -1269 | -1628 |
Correlation of BCVA change with degree of capillary non-perfusion before and after injections (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | Logmar (Mean) |
|---|---|
| Bevacizumab Group | -0.21 |
Effect of repeated intravitreal Anti-VEGF injections on Foveal Avascular Zone (FAZ) area measured using the freehand tool of ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | mm^2 (Mean) |
|---|---|
| Bevacizumab Group | 0.03 |
Effect of repeated intravitreal Anti-VEGF injections on macular capillary density using the change in the skeletonized vascular density and fractal dimension measured by ImageJ (NCT03246152)
Timeframe: At baseline and after 3-6 consecutive monthly injections.
| Intervention | percentage of vascularity (Mean) |
|---|---|
| Bevacizumab Group | -2.5 |
"The degree of cell and flare was recorded at each visit during the course of the trial in the injected eye.~In uveitis, severely inflamed vessels leak protein which clouds the normally clear aqueous. This looks hazy with the slit lamp. If severe, it disperses the light beam, causing flare.~White or red blood cells may be observed: the presence of inflammatory cells in the anterior chamber suggests inflammation of the iris and ciliary body.~Blood cells: grading of blood cells in the anterior chamber is as follows:~0 - None.~1+ - faint (barely detectable).~2+ - moderate (clear iris and lens details).~3+ - moderate (hazy iris and lens details).~4+ - intense (fibrin deposits, coagulated aqueous)." (NCT00790803)
Timeframe: 32 weeks
| Intervention | participants (Number) |
|---|---|
| Macugen | 0 |
No changes were to be made in immunodulatory medications of the patients unless needed for safety after in initiation of Macugen therapy. (NCT00790803)
Timeframe: 32 weeks
| Intervention | participants (Number) |
|---|---|
| Macugen | 0 |
Patients retinal thickness was measured at each visit bu imaging to monitor increase or decrease in thickness. (NCT00790803)
Timeframe: 32 weeks
| Intervention | participants (Number) |
|---|---|
| Macugen | 2 |
The primary outcome was an improvement in VA greater than or equal to fifteen letters on the EDTRS chart. (NCT00790803)
Timeframe: 32 weeks
| Intervention | participants (Number) |
|---|---|
| Macugen | 1 |
Patients best corrected visual acuity was measured at each visit to monitor gain or loss of letters on the EDTRS chart. (NCT00790803)
Timeframe: 32 weeks
| Intervention | paticipants (Number) |
|---|---|
| Macugen | 5 |
Number of Participants with Postoperative Vitreous Hemorrhage (NCT00548197)
Timeframe: Last follow up, an average of 7 months post-operation
| Intervention | Participants (Count of Participants) |
|---|---|
| Intervention Group | 0 |
| Control Group | 7 |
Post operative best corrected visual acuity ( best distance vision with eyeglasses or contact lenses) (NCT00548197)
Timeframe: last follow up, an average of 7 months post-operation
| Intervention | LogMar (Mean) |
|---|---|
| Intervention | 1.1 |
| Control | 1.4 |
15 reviews available for 2-propanol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[Neovascular glaucoma--etipathogeny and diagnosis].
Topics: Arterial Occlusive Diseases; Diabetic Retinopathy; Diagnosis, Differential; Eye; Eye Neoplasms; Glau | 2012 |
Recent advances in the management of neovascular glaucoma.
Topics: Angiogenesis Inhibitors; Filtering Surgery; Glaucoma, Neovascular; Humans; Iris; Laser Therapy; Neov | 2013 |
[Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Bevacizumab; Capillary Permeability; Cornea; Glauco | 2015 |
Cataract surgery and diabetic retinopathy.
Topics: Cataract; Cataract Extraction; Diabetic Retinopathy; Disease Progression; Humans; Iris; Macular Edem | 2003 |
Ocular neovascularization: basic mechanisms and therapeutic advances.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Clinical Trials as Topic; Humans; Iris; Neova | 2007 |
Ocular photodynamic therapy--standard applications and new indications (part 1). Review of the literature and personal experience.
Topics: Choroidal Neovascularization; Clinical Trials as Topic; Glaucoma, Neovascular; Humans; Iris; Neovasc | 2007 |
Bevacizumab in glaucoma: a review.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Fil | 2007 |
[Clinical picture and treatment of hemorrhagic glaucoma].
Topics: Diabetic Retinopathy; Diagnosis, Differential; Eye Diseases; Glaucoma; Hemorrhage; Humans; Iris; Met | 1982 |
Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.
Topics: Adult; Age Factors; Aged; Anterior Chamber; Eye; Female; Glaucoma; Humans; Iris; Ischemia; Male; Mid | 1983 |
Retinal neovascularization.
Topics: Animals; Eye Neoplasms; Fluorescein Angiography; Humans; Infant, Newborn; Iris; Ischemia; Macaca fas | 1983 |
Other uses of laser in the anterior segment of the eye.
Topics: Anterior Eye Segment; Cataract Extraction; Ciliary Body; Cysts; Eye; Eye Injuries; Humans; Iris; Iri | 1984 |
The preclinical evaluation of angiogenesis inhibitors.
Topics: Allantois; Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Chick Embryo; Chorion; Co | 1997 |
Central retinal vein occlusion: what's the story?
Topics: Arteriosclerosis; Humans; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Risk Factors | 1997 |
Central retinal vein occlusion: what's the story?
Topics: Arteriosclerosis; Humans; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Risk Factors | 1997 |
Central retinal vein occlusion: what's the story?
Topics: Arteriosclerosis; Humans; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Risk Factors | 1997 |
Central retinal vein occlusion: what's the story?
Topics: Arteriosclerosis; Humans; Iris; Neovascularization, Pathologic; Retinal Vein Occlusion; Risk Factors | 1997 |
Angiogenic factors in the development of diabetic iris neovascularization and retinopathy.
Topics: Angiogenesis Inducing Agents; Cell Division; Diabetic Retinopathy; Endothelium, Vascular; Humans; Ir | 1998 |
Ocular angiogenesis.
Topics: Animals; Choroid; Cornea; Eye; Humans; Iris; Neovascularization, Pathologic; Retina; Uvea; Vitreous | 1986 |
16 trials available for 2-propanol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Topical bevacizumab for neovascular glaucoma: a pilot study.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal | 2014 |
Long-term effect of dalteparin in the prevention of neovascularization of iris in recent-onset central retinal vein occlusion.
Topics: Aspirin; Dalteparin; Female; Fibrinolytic Agents; Humans; Iris; Male; Middle Aged; Neovascularizatio | 2008 |
Effect of intracameral bevacizumab injection on corneal endothelial cells: an in vivo evaluation.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Anterior Eye Segment; Antibodies, Monoclonal; Antibodies | 2009 |
SCORE Study report #11: incidences of neovascular events in eyes with retinal vein occlusion.
Topics: Aged; Capillaries; Female; Glaucoma, Neovascular; Glucocorticoids; Humans; Incidence; Iris; Ischemia | 2011 |
Photoreceptor layer regeneration is detectable in the human retina imaged by SD-OCT after laser treatment using subthreshold laser power.
Topics: Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Iri | 2012 |
Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocu | 2006 |
Goniophotocoagulation in the management of rubeosis iridis.
Topics: Adult; Aged; Argon; Clinical Trials as Topic; Follow-Up Studies; Glaucoma; Glaucoma, Open-Angle; Hum | 1981 |
Central vein occlusion study of photocoagulation therapy. Baseline findings. Central Vein Occlusion Study Group.
Topics: Adult; Aged; Aged, 80 and over; Female; Glaucoma, Neovascular; Humans; Iris; Ischemia; Laser Coagula | 1993 |
Central Vein Occlusion Study: photographic protocol and early natural history.
Topics: Fluorescein Angiography; Fundus Oculi; Humans; Iris; Laser Coagulation; Macular Edema; Neovasculariz | 1994 |
Baseline and early natural history report. The Central Vein Occlusion Study.
Topics: Adult; Aged; Aged, 80 and over; Edema; Female; Follow-Up Studies; Humans; Iris; Light Coagulation; M | 1993 |
Baseline and early natural history report. The Central Vein Occlusion Study.
Topics: Adult; Aged; Aged, 80 and over; Edema; Female; Follow-Up Studies; Humans; Iris; Light Coagulation; M | 1993 |
Baseline and early natural history report. The Central Vein Occlusion Study.
Topics: Adult; Aged; Aged, 80 and over; Edema; Female; Follow-Up Studies; Humans; Iris; Light Coagulation; M | 1993 |
Baseline and early natural history report. The Central Vein Occlusion Study.
Topics: Adult; Aged; Aged, 80 and over; Edema; Female; Follow-Up Studies; Humans; Iris; Light Coagulation; M | 1993 |
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Fundus Oculi; Humans; Iris; Ischemia; Las | 1995 |
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Fundus Oculi; Humans; Iris; Ischemia; Las | 1995 |
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Fundus Oculi; Humans; Iris; Ischemia; Las | 1995 |
A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Fundus Oculi; Humans; Iris; Ischemia; Las | 1995 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group.
Topics: Aged; Cohort Studies; Female; Glaucoma; Guidelines as Topic; Humans; Iris; Light Coagulation; Male; | 1997 |
Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Eye Enucleation; Female; Humans; Iris; Male; Melanom | 1997 |
Iris angiographic changes in multifocal chorioretinitis with panuveitis.
Topics: Aged; Aged, 80 and over; Cataract Extraction; Chorioretinitis; Chronic Disease; Female; Fluorescein | 1999 |
Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone.
Topics: Aged; Aged, 80 and over; Crystallization; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Gluco | 2001 |
Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study.
Topics: Aged; Analysis of Variance; Clinical Protocols; Data Interpretation, Statistical; Female; Glaucoma, | 1990 |
354 other studies available for 2-propanol and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Hyperacute iris neovascularization following cataract surgery.
Topics: Aged; Bevacizumab; Cataract; Humans; Iris; Macular Edema; Male; Neovascularization, Pathologic; Reti | 2022 |
Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center.
Topics: Adolescent; Adult; Aged; Aneurysm; Child; Child, Preschool; Eye Enucleation; Female; Fluorescein Ang | 2019 |
A Painful Right Eye.
Topics: Child, Preschool; Eye; Eye Pain; Humans; Iris; Male; Neovascularization, Pathologic; Retinal Neoplas | 2020 |
Anterior Segment Optical Coherence Tomography Angiography of Iris Neovascularization After Intravitreal Ranibizumab and Panretinal Photocoagulation.
Topics: Angiogenesis Inhibitors; Anterior Eye Segment; Combined Modality Therapy; Fluorescein Angiography; H | 2020 |
[Blood, where no blood should be].
Topics: Humans; Iris; Neovascularization, Pathologic; Retina; Vascular Endothelial Growth Factor A; Vascular | 2021 |
Anterior segment optical coherence tomography angiography for iris vasculature in pigmented eyes.
Topics: Adult; Anterior Eye Segment; Eye Color; Female; Fluorescein Angiography; Humans; Iris; Male; Neovasc | 2021 |
Iris melanoma with neovascularization in sector melanocytosis controlled with
Topics: Bevacizumab; Humans; Iodine Radioisotopes; Iris; Iris Neoplasms; Melanoma; Neovascularization, Patho | 2021 |
Iris metastasis as the initial presentation of metastatic esophageal cancer diagnosed by fine needle aspiration biopsy: A case report.
Topics: Acetazolamide; Administration, Oral; Aged; Anterior Chamber; Biopsy, Fine-Needle; Carbonic Anhydrase | 2021 |
The Penumbra Obscura Stimulates Iris Neovascularisation after Isolated Central Retinal Artery Occlusion.
Topics: Humans; Iris; Neovascularization, Pathologic; Retinal Artery Occlusion; Retinal Vein Occlusion | 2017 |
Anterior Segment Optical Coherence Tomography Angiography for Identification of Iris Vasculature and Staging of Iris Neovascularization: A Pilot Study.
Topics: Adult; Aged; Anterior Eye Segment; Cross-Sectional Studies; Female; Fluorescein Angiography; Follow- | 2017 |
A novel in vivo model of puncture-induced iris neovascularization.
Topics: Animals; Blotting, Western; Disease Models, Animal; Female; Fluorescent Antibody Technique; Iris; Ma | 2017 |
Changes in Ocular Hemodynamics after Carotid Artery Angioplasty and Stenting (CAAS) in Patients with Different Severity of Ocular Ischemic Syndrome.
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon; Blood Flow Velocity; Carbonic Anhydrase Inh | 2018 |
Comparison of anterior segment optical coherence tomography angiography and fluorescein angiography for iris vasculature analysis.
Topics: Anterior Eye Segment; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Iris; Iris D | 2018 |
Puncture-Induced Iris Neovascularization as a Mouse Model of Rubeosis Iridis.
Topics: Animals; Disease Models, Animal; Humans; Iris; Mice; Mice, Inbred BALB C; Neovascularization, Pathol | 2018 |
Ocular toxicity of reduced graphene oxide or graphene oxide exposure in mouse eyes.
Topics: Animals; Antioxidants; Apoptosis; Cell Survival; Cells, Cultured; Cornea; Epithelial Cells; Eye; Gra | 2018 |
Blood Vessels and Lymphatic Vessels in the Cornea and Iris After Penetrating Keratoplasty.
Topics: Animals; Blood Vessels; Ciliary Body; Cornea; Corneal Neovascularization; Disease Models, Animal; Gr | 2019 |
UPARANT is an effective antiangiogenic agent in a mouse model of rubeosis iridis.
Topics: Angiogenesis Inhibitors; Animals; Biomarkers; Disease Models, Animal; Female; Inflammation; Iris; Ma | 2019 |
Observation of treated iris neovascularization by swept-source-based en-face anterior-segment optical coherence tomography angiography.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Female; Fluorescein Angiography; Humans; Iris; Iris Dise | 2019 |
Optimal area of retinal photocoagulation necessary for suppressing active iris neovascularisation associated with diabetic retinopathy.
Topics: Diabetic Retinopathy; Female; Humans; Iris; Iris Diseases; Light Coagulation; Male; Middle Aged; Neo | 2014 |
Deterioration of glaucoma after carotid endarterectomy.
Topics: Blindness; Corneal Edema; Diabetic Retinopathy; Disease Progression; Endarterectomy, Carotid; Eye; G | 2013 |
Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihype | 2013 |
Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihype | 2013 |
Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihype | 2013 |
Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antihype | 2013 |
[Nocturnal dipping of heart rate in patients with proliferative diabetic retinopathy and iris and/or angle neovascularization].
Topics: Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Heart Rate; Humans; Iris; Male; Middle Aged; | 2013 |
Dilated iris vasculature in the setting of the neonatal hypoxic encephelopathy.
Topics: Adult; Female; Gestational Age; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Intraocular Pressu | 2015 |
Images in clinical medicine. Neovascular festoons on the iris.
Topics: Aged; Humans; Hypertension; Iris; Male; Neovascularization, Pathologic; Retinal Vein Occlusion | 2013 |
Bilateral retinal vein occlusion and rubeosis irides: lessons to learn.
Topics: Adult; Antibodies, Monoclonal, Humanized; Female; Humans; Iris; Laser Coagulation; Neovascularizatio | 2013 |
Iris rubeosis, severe respiratory failure and retinopathy of prematurity--case report.
Topics: Adolescent; Antibodies, Monoclonal; Combined Modality Therapy; Fatal Outcome; Female; Humans; Infant | 2014 |
Regression of iris neovascularisation secondary to diabetic retinopathy with subconjunctival anti-VEGF therapy.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Cataract; Diabetic Retinopathy; Female; Humans; Intr | 2014 |
Ocular findings at initial pan retinal photocoagulation for proliferative diabetic retinopathy predict the need for future pars plana vitrectomy.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Humans; Iris; Laser Coagulation; Male; | 2014 |
Vascular endothelial growth factor and its soluble receptors-1 and -2 in iris neovascularization and neovascular glaucoma.
Topics: Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; Humans; Intr | 2014 |
Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agent | 2014 |
The effect of central retinal venous pressure in patients with central retinal vein occlusion and a high mean area of nonperfusion.
Topics: Aged; Blood Pressure; Cohort Studies; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Ir | 2014 |
Expression of cytokines on the iris of patients with neovascular glaucoma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Cytokines; Diabetic | 2015 |
Retcam fluorescein angiography findings in eyes with advanced retinoblastoma.
Topics: Child, Preschool; Female; Fluorescein Angiography; Humans; Infant; Infant, Newborn; Iris; Male; Neop | 2014 |
Sympathetic ophthalmia after diode laser cyclophotocoagulation: now an issue in informed consent.
Topics: Adult; Blindness; Ciliary Body; Duty to Warn; Eye Pain; Humans; Informed Consent; Intraocular Pressu | 2014 |
Staphylococcus Alpha-Toxin Action on the Rabbit Iris: Toxic Effects and Their Inhibition.
Topics: Animals; Anterior Chamber; Antibodies, Blocking; Bacterial Toxins; beta-Cyclodextrins; Cholesterol; | 2015 |
Optimal area of retinal photocoagulation necessary for suppressing active iris neovascularization associated with diabetic retinopathy.
Topics: Diabetic Retinopathy; Female; Humans; Iris; Iris Diseases; Light Coagulation; Male; Neovascularizati | 2015 |
Intravitreal aflibercept for rubeosis iridis secondary to proliferative diabetic retinopathy.
Topics: Diabetic Retinopathy; Humans; Intravitreal Injections; Iris; Low-Level Light Therapy; Male; Middle A | 2015 |
Visualization of a Hematoma of the Cloquet Canal.
Topics: Acute Disease; Glaucoma, Angle-Closure; Hematoma; Humans; Iris; Laser Coagulation; Magnetic Resonanc | 2016 |
Acute retinal necrosis and ocular neovascularization caused by cytomegalovirus following intravitreal dexamethasone implant (Ozurdex
Topics: Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Drug Implants; D | 2016 |
Incidence and Clinical Features of Neovascularization of the Iris following Acute Central Retinal Artery Occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Hu | 2016 |
Iris Vascular Tufts.
Topics: Aged; Capillary Permeability; Coloring Agents; Female; Fluorescein Angiography; Humans; Hyphema; Ind | 2016 |
Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2009 |
Congenital pupillary-iris-lens membrane with goniodysgenesis: a rare cause of glaucoma and vision loss.
Topics: Anterior Eye Segment; Blindness; Child; Eye Abnormalities; Eye Enucleation; Glaucoma, Neovascular; H | 2009 |
Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anterior Chamber; Antibodies, Monoclonal; A | 2009 |
[Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis].
Topics: Adult; Aged; Blood Flow Velocity; Ciliary Arteries; Diabetic Retinopathy; Diastole; Eye; Female; Hum | 2009 |
Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Angiogenesis Inhibitors; Antibodies, Monoclonal; Anti | 2009 |
Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizuma | 2010 |
The effect of bevacizumab for anterior segment neovascularization after silicone oil removal in eyes with previous vitreoretinal surgery.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2010 |
Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chemotherapy, A | 2010 |
Canine pre-iridal fibrovascular membranes: morphologic and immunohistochemical investigations.
Topics: Adenoma; Animals; Coloring Agents; Cyclooxygenase 2; Dog Diseases; Dogs; Iris; Iris Neoplasms; Neova | 2010 |
Intravitreal bevacizumab for iris neovascularization following proton beam irradiation for choroidal melanoma.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizuma | 2010 |
Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2010 |
Primary iris neovascularization in neurofibromatosis type 1.
Topics: Adolescent; Amaurosis Fugax; Humans; Iris; Iris Diseases; Male; Neovascularization, Pathologic; Neur | 2010 |
Antivascular endothelial growth factors in anterior segment diseases.
Topics: Administration, Topical; Angiogenesis Inhibitors; Anterior Eye Segment; Antibodies, Monoclonal; Anti | 2010 |
Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization.
Topics: Animals; Disease Models, Animal; Fluorescein Angiography; Green Fluorescent Proteins; Haplorhini; Im | 2010 |
Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2010 |
Resolution of iris neovascularization following chemoreduction of retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Etoposide; Female; Hu | 2010 |
A case of Joubert syndrome with features of ocular neovascularization.
Topics: Abnormalities, Multiple; Cerebellar Diseases; Cerebellum; Child; Electroretinography; Evoked Potenti | 2010 |
Ophthalmodynamometric pressure in eyes with proliferative diabetic retinopathy measured during pars plana vitrectomy.
Topics: Blood Glucose; Blood Pressure; Body Mass Index; Cholesterol; Diabetic Retinopathy; Female; Fluoresce | 2011 |
Relationship between sleep-disordered breathing and iris and/or angle neovascularization in proliferative diabetic retinopathy cases.
Topics: Aged; Anterior Chamber; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fe | 2011 |
[Long-term clinical outcome of radial optic neurotomy].
Topics: Aged; Cataract; Decompression, Surgical; Female; Follow-Up Studies; Humans; Intraocular Pressure; Ir | 2010 |
Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2011 |
Rabbit rubeosis iridis induced by intravitreal latex-derived angiogenic fraction.
Topics: Angiogenesis Inducing Agents; Animals; Disease Models, Animal; Disease Progression; Drug Carriers; F | 2011 |
Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; | 2012 |
Comparative gene expression profiling of human umbilical vein endothelial cells and ocular vascular endothelial cells.
Topics: Capillaries; Cell Division; Choroid; Endothelial Cells; Gene Expression Profiling; Human Umbilical V | 2012 |
Primary pulmonary arterial hypertension diagnosed via its ophthalmic features in an adult: diagnosis and therapeutic challenges.
Topics: Antihypertensive Agents; Blindness; Familial Primary Pulmonary Hypertension; Fluorescein Angiography | 2012 |
[Ocular ischemic syndrome with rubeosis iridis].
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Eye Diseases; Fluorescein An | 2012 |
Intrasilicone bevacizumab injection for iris neovascularization after vitrectomy for proliferative diabetic retinopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; | 2013 |
Regression of rubeosis in the fellow eye after intravitreal ranibizumab injection.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Diabetic Retinopathy; Female; Fluo | 2013 |
Laser photocoagulation of an avulsed persistent pupillary membrane vessel causing recurrent hyphaema.
Topics: Eye Abnormalities; Fluorescein Angiography; Gonioscopy; Humans; Hyphema; Iris; Laser Coagulation; Ma | 2013 |
Dexamethasone implants and neovascular glaucoma in central retinal vein occlusion.
Topics: Dexamethasone; Drug Implants; Fluorescein Angiography; Glaucoma, Neovascular; Glucocorticoids; Gonio | 2013 |
Intravitreal bevacizumab in the treatment of diabetic ocular neovascularization.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizu | 2013 |
Intravitreal triamcinolone acetonide for cataract surgery with iris neovascularization.
Topics: Aged; Cataract; Cataract Extraction; Female; Glucocorticoids; Humans; Injections; Iris; Lenses, Intr | 2002 |
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Capillary Permeability; Electrophoresis, Capillary; E | 2002 |
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Capillary Permeability; Electrophoresis, Capillary; E | 2002 |
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Capillary Permeability; Electrophoresis, Capillary; E | 2002 |
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Capillary Permeability; Electrophoresis, Capillary; E | 2002 |
Effect of squalamine on iris neovascularization in monkeys.
Topics: Angiogenesis Inhibitors; Animals; Cholestanols; Disease Models, Animal; Fluorescein Angiography; Inf | 2002 |
Retinochoroidal collateral veins protect against anterior segment neovascularization after central retinal vein occlusion.
Topics: Aged; Aged, 80 and over; Anterior Eye Segment; Choroid; Collateral Circulation; Female; Fluorescein | 2003 |
[Steroid therapy of oedematous and neovascular eye diseases].
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Injections; Iris; Macular Edema; Neovascularizati | 2003 |
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.
Topics: Aged; Anti-Inflammatory Agents; Eye; Humans; Injections; Intraocular Pressure; Iris; Ischemia; Male; | 2003 |
Clinical variables and their relation to visual outcome after vitrectomy in eyes with diabetic retinal traction detachment.
Topics: Adult; Age Factors; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fema | 2004 |
Roles of thrombospondin-1 and -2 in regulating corneal and iris angiogenesis.
Topics: Animals; Blotting, Western; Cornea; Corneal Neovascularization; Female; Gene Deletion; Iris; Male; M | 2004 |
Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Fluorescein Angiography; Glaucoma, Neovascular | 2004 |
The fluorescein angiography revolution: a breakthrough with sustained impact.
Topics: Choroidal Neovascularization; Fluorescein Angiography; Humans; Iris; Neovascularization, Pathologic; | 2004 |
Ocular complications after iodine brachytherapy for large uveal melanomas.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Cataract; Eye Diseases; Female; Glaucoma; Humans; Inc | 2004 |
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Topics: Adult; Aged; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; | 2004 |
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Topics: Adult; Aged; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; | 2004 |
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Topics: Adult; Aged; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; | 2004 |
Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Topics: Adult; Aged; Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; | 2004 |
Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases.
Topics: Aged; Aged, 80 and over; Arterial Occlusive Diseases; Eye; Female; Humans; Infant; Iris; Macular Ede | 1981 |
An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization.
Topics: Animals; Disease Models, Animal; Fluorescein Angiography; Fluorescein-5-isothiocyanate; Genetic Ther | 2005 |
Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Brachytherapy; Female; Humans; Iodine Radioisotope | 2005 |
[Iris neovascularization as a complication of central artery occlusion].
Topics: Comorbidity; Cross-Sectional Studies; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Neovascu | 2005 |
[Rubeosis iridis (neovascularisation on the iris)].
Topics: Capillaries; Diagnosis, Differential; Disease Progression; Gonioscopy; Humans; Iris; Iris Diseases; | 2005 |
Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Iris; Ischemia; Light; Male; Middle Aged; Neovasc | 2005 |
Proton beam therapy and iris neovascularisation in uveal melanoma.
Topics: Adult; Aged; Atrophy; Female; Fibroblast Growth Factor 2; Follow-Up Studies; Humans; Immunoenzyme Te | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Diabetic Retinopathy; Female | 2006 |
Clinicopathological features of severe corneal blood staining associated with proliferative diabetic retinopathy.
Topics: Blood; Corneal Diseases; Diabetic Retinopathy; Humans; Hyphema; Intraocular Pressure; Iris; Keratopl | 2006 |
Rubeosis iridis after bilateral cataract surgery and its spontaneous regression in a patient with myotonic dystrophy.
Topics: Female; Functional Laterality; Humans; Iris; Lens Implantation, Intraocular; Middle Aged; Myotonic D | 2006 |
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy.
Topics: Aptamers, Nucleotide; Chemotherapy, Adjuvant; Diabetic Retinopathy; Glaucoma Drainage Implants; Glau | 2006 |
Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizum | 2006 |
Intracameral bevacizumab for iris rubeosis.
Topics: Aged; Angiogenesis Inhibitors; Anterior Chamber; Antibodies, Monoclonal; Antibodies, Monoclonal, Hum | 2006 |
Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.
Topics: Aged; Anterior Eye Segment; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; | 2006 |
Resolution of iris neovascularization following chemoreduction of advanced retinoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Fluorescein Angiogra | 2006 |
Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
Topics: Aged; Angiogenesis Inhibitors; Anterior Eye Segment; Antibodies, Monoclonal; Antibodies, Monoclonal, | 2006 |
Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia.
Topics: Adult; Anterior Eye Segment; Atrophy; Cryoglobulinemia; Glaucoma, Neovascular; Humans; Iris; Ischemi | 2006 |
Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclo | 2006 |
Opaque coating of an intraocular lens and regression of iris neovascularization following injection of triamcinolone acetonide into the anterior chamber.
Topics: Anterior Chamber; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Iris; Laser Coa | 2006 |
Central retinal vein occlusion: the therapeutic options.
Topics: Combined Modality Therapy; Fluorescein Angiography; Glaucoma, Neovascular; Humans; Iris; Macular Ede | 2007 |
Regression of neovascular posterior capsule vessels by intravitreal bevacizumab.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizuma | 2007 |
Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizuma | 2007 |
Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Flu | 2008 |
Bevacizumab (Avastin) for the treatment of neovascular glaucoma.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanize | 2007 |
[Central retinal vein occlusion].
Topics: Comorbidity; Epiretinal Membrane; Fluorescein Angiography; Follow-Up Studies; Humans; Iris; Neovascu | 2007 |
Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizum | 2008 |
Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study.
Topics: Brachytherapy; Choroid Neoplasms; Eye Enucleation; Humans; Iodine Radioisotopes; Iris; Melanoma; Neo | 2008 |
Verteporfin photodynamic therapy for anterior segment neovascularization secondary to ischaemic central retinal vein occlusion.
Topics: Aged; Anterior Eye Segment; Blood Vessels; Female; Fluorescein Angiography; Humans; Intraocular Pres | 2008 |
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bev | 2008 |
Corneal endothelial overgrowth of angle and iris. Evidence of myoblastic differentiation in three cases.
Topics: Adolescent; Aged; Anterior Chamber; Cataract; Cell Differentiation; Cornea; Diabetic Retinopathy; En | 1984 |
Characteristics of the hemispheric retinal vein occlusion.
Topics: Adult; Aged; Female; Fluorescein Angiography; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Iris; | 1984 |
[Neovascular glaucoma caused by branch vein occlusion and deficiency of carotid-encephalic circulation: pathogenetic correlation].
Topics: Aged; Carotid Artery Diseases; Cerebrovascular Disorders; Eye; Fluorescein Angiography; Glaucoma; Hu | 1984 |
The pathogenesis of ocular vascular disorders.
Topics: Aneurysm; Cornea; Endophthalmitis; Exudates and Transudates; Eye; Eye Diseases; Humans; Iris; Ischem | 1984 |
Neovascular glaucoma in a patient with X-linked juvenile retinoschisis.
Topics: Adolescent; Female; Genetic Linkage; Glaucoma; Humans; Iris; Male; Neovascularization, Pathologic; R | 1980 |
Diabetes and the eye.
Topics: Cranial Nerve Diseases; Diabetes Complications; Diabetic Retinopathy; Eye; Glaucoma; Humans; Iris; N | 1984 |
Experimental ocular angiogenesis.
Topics: Animals; Carcinoma; Choroid; Conjunctiva; Cornea; Iris; Neoplasms, Experimental; Neovascularization, | 1980 |
Ocular angiogenesis: a model.
Topics: Animals; Choroid; Disease Models, Animal; Eye Neoplasms; Iris; Neoplasm Transplantation; Neovascular | 1980 |
Laser treatment of the anterior segment.
Topics: Glaucoma; Humans; Iris; Laser Therapy; Neovascularization, Pathologic | 1980 |
[Fluoresceinographic trials of correlating vascular changes in the retina and iris in diabetes (author's transl)].
Topics: Adult; Aged; Capillary Permeability; Diabetes Mellitus; Diabetic Retinopathy; Female; Fluorescein An | 1980 |
Modified trabeculectomy: a new procedure for neovascular glaucoma.
Topics: Glaucoma; Humans; Iris; Neovascularization, Pathologic; Sclera; Suture Techniques; Trabecular Meshwo | 1980 |
Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.
Topics: Argon; Diabetic Retinopathy; Fluorescein Angiography; Humans; Iris; Ischemia; Laser Therapy; Light C | 1980 |
[Circular neovascularization of the circulus arteriosus iridis minor].
Topics: Adult; Aged; Angiography; Arterial Occlusive Diseases; Diabetic Angiopathies; Female; Humans; Iris; | 1980 |
Iris neovascular tufts.
Topics: Age Factors; Fluorescein Angiography; Humans; Iris; Iris Diseases; Middle Aged; Neovascularization, | 1980 |
A study of the anterior chamber before and after implantation of the Choyce Mark VIII lens.
Topics: Anterior Chamber; Eye Diseases; Humans; Iris; Lenses, Intraocular; Neovascularization, Pathologic; U | 1980 |
[The significance of ciliary circulation in the development of iris neovascularisation (author's transl)].
Topics: Aged; Arterial Occlusive Diseases; Ciliary Body; Fluorescein Angiography; Humans; Iris; Ischemia; Ma | 1980 |
Iris neovascularisation in eyes with pseudoexfoliation syndrome.
Topics: Aged; Basement Membrane; Capillaries; Endothelium; Female; Humans; Iris; Lens Diseases; Male; Micros | 1981 |
Iris neovascular tufts.
Topics: Aged; Female; Humans; Hypertension; Insulin; Insulin Secretion; Iris; Neovascularization, Pathologic | 1980 |
[Vascular glaucoma].
Topics: Diabetic Retinopathy; Eye; Fluorescein Angiography; Glaucoma; Humans; Iris; Neovascularization, Path | 1981 |
An approach to the management of neovascularization of the iris and secondary glaucoma.
Topics: Adult; Diabetic Angiopathies; Diabetic Retinopathy; Female; Glaucoma; Humans; Iris; Iris Diseases; M | 1980 |
Spontaneous anterior chamber hemorrhage from the iris: a unique cinematographic documentation.
Topics: Cineradiography; Female; Fluorescein Angiography; Hemorrhage; Humans; Hyphema; Iris; Middle Aged; Ne | 1980 |
Ocular angiogenesis in disease states.
Topics: Child; Cornea; Eye; Humans; Iris; Ischemia; Lactates; Neovascularization, Pathologic; Oxygen; Retina | 1980 |
[Changes in the retina accompanying the Osler syndrome (author's transl)].
Topics: Blindness; Child; Glaucoma; Humans; Iris; Iritis; Male; Neovascularization, Pathologic; Retina; Reti | 1981 |
Optic nerve glioma and neovascular glaucoma: report of a case.
Topics: Blindness; Child; Cranial Nerve Neoplasms; Female; Glaucoma; Glioma; Humans; Iris; Neovascularizatio | 1982 |
Neovascular glaucoma following central retinal vein obstruction.
Topics: Adult; Aged; Constriction, Pathologic; Female; Fluorescein Angiography; Glaucoma; Humans; Iris; Isch | 1981 |
A grading system for iris neovascularization. Prognostic implications for treatment.
Topics: Adolescent; Adult; Aged; Anterior Chamber; Constriction, Pathologic; Cryosurgery; Diabetes Complicat | 1981 |
Ocular neovascularization with retinal vascular occlusion. I. Association with experimental retinal vein occlusion.
Topics: Animals; Capillary Permeability; Disease Models, Animal; Intraocular Pressure; Iris; Macaca fascicul | 1982 |
[Secondary fluorescence of intraocular vessels of the anterior segment of the rat eye after local drug application (author's transl)].
Topics: Administration, Topical; Animals; Capillary Permeability; Ciliary Body; Dexamethasone; Gentamicins; | 1982 |
Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer.
Topics: Age Factors; Animals; Breast; Female; Humans; Iris; Middle Aged; Neovascularization, Pathologic; Pre | 1982 |
A case of diabetic rubeosis iridis without significant observable retinopathy.
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Insulin; Iris; Male; Middle Aged; Neovascularizat | 1982 |
Endophotocoagulation.
Topics: Glaucoma; Humans; Iris; Laser Therapy; Lasers; Neovascularization, Pathologic; Retinal Detachment; R | 1981 |
The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy.
Topics: Cataract Extraction; Diabetic Retinopathy; Female; Glaucoma; Humans; Iris; Lens, Crystalline; Male; | 1983 |
Vitrectomy for diabetic vitreous hemorrhage.
Topics: Adult; Aged; Diabetes Complications; Eye Diseases; Female; Glaucoma; Hemorrhage; Humans; Iris; Male; | 1983 |
Vitrectomy for diabetic traction retinal detachment involving the macula.
Topics: Cataract Extraction; Diabetic Retinopathy; Glaucoma; Humans; Iris; Lens, Crystalline; Macula Lutea; | 1983 |
Vitrectomy for diabetic rhegmatogenous retinal detachment.
Topics: Diabetic Retinopathy; Glaucoma; Humans; Iris; Methods; Neovascularization, Pathologic; Postoperative | 1983 |
Fluorescein angiography and fluorophotometry of the iris in pseudoexfoliation of the lens capsule.
Topics: Aged; Aphakia, Postcataract; Female; Fluorescein Angiography; Fluorometry; Humans; Iris; Lens Diseas | 1983 |
[Development and classification of neovascular glaucoma in diabetic eye disease: histopathological study].
Topics: Diabetes Complications; Glaucoma; Humans; Iris; Neovascularization, Pathologic; Trabecular Meshwork | 1982 |
[Neovascular glaucoma secondary to carotid thrombosis].
Topics: Carotid Artery Thrombosis; Fluorescein Angiography; Glaucoma; Humans; Iris; Male; Middle Aged; Neova | 1982 |
Pathology of anterior chamber angle in diabetic neovascular glaucoma: extension of corneal endothelium onto iris surface.
Topics: Adult; Anterior Chamber; Cornea; Diabetic Retinopathy; Endothelium; Eye Diseases; Female; Glaucoma; | 1983 |
Value of fluorescein angiography of the iris in uveitis.
Topics: Adult; Aged; Female; Fluorescein Angiography; Humans; Iris; Iris Diseases; Iritis; Male; Middle Aged | 1981 |
Carbon dioxide laser trabeculostomy for the treatment of neovascular glaucoma.
Topics: Female; Glaucoma; Humans; Intraocular Pressure; Iris; Laser Therapy; Male; Middle Aged; Neovasculari | 1982 |
[The value of fluorescein angiography of the iris in the monitoring of rubeosis iridis treated with panretinal photocoagulation].
Topics: Adult; Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Iris; Light Coagulation; | 1982 |
Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications.
Topics: Adult; Aged; Cataract; Corneal Diseases; Diabetic Retinopathy; Female; Hemorrhage; Humans; Iris; Iri | 1983 |
[Sarcoidosis and rubeosis iridis].
Topics: Adult; Humans; Iris; Male; Neovascularization, Pathologic; Ocular Hypertension; Prednisone; Sarcoido | 1983 |
Iris trauma in metal two-loop intraocular lens implants.
Topics: Aged; Fluorescein Angiography; Follow-Up Studies; Humans; Iris; Lenses, Intraocular; Neovascularizat | 1982 |
The myofibroblastic component of rubeosis iridis.
Topics: Fibroblasts; Glaucoma; Humans; Iris; Iris Diseases; Microscopy, Electron; Microscopy, Electron, Scan | 1983 |
Neovascular glaucoma and vitreous hemorrhage following cataract surgery in patients with diabetes mellitus.
Topics: Cataract; Cataract Extraction; Diabetes Complications; Diabetic Retinopathy; Eye Diseases; Female; G | 1983 |
Carbon dioxide laser trabeculostomy for the treatment of neovascular glaucoma.
Topics: Diabetic Retinopathy; Female; Glaucoma; Humans; Iris; Laser Therapy; Lasers; Male; Methods; Middle A | 1983 |
[Iris angiography before acute glaucoma].
Topics: Acute Disease; Aged; Female; Fluorescein Angiography; Glaucoma; Humans; Iris; Male; Middle Aged; Neo | 1983 |
[Iris angiographic findings after intra- and extracapsular cataract extraction and implantation of a Binkhorst 4-loop lens].
Topics: Cataract Extraction; Fluorescein Angiography; Follow-Up Studies; Humans; Iris; Iritis; Lenses, Intra | 1983 |
Low tension neovascular glaucoma treated by draining implant.
Topics: Drainage; Glaucoma; Humans; Iris; Male; Middle Aged; Neovascularization, Pathologic | 1983 |
Ischemic oculopathy.
Topics: Arterial Occlusive Diseases; Carotid Artery Diseases; Carotid Artery, Internal; Eye; Female; Glaucom | 1983 |
Neovascularization of the iris: an experimental model in cats.
Topics: Animals; Cats; Disease Models, Animal; Female; Intraocular Pressure; Iris; Lens, Crystalline; Male; | 1984 |
A report of iris neovascularization: an indication for carotid endarterectomy.
Topics: Aged; Carotid Arteries; Carotid Artery Diseases; Constriction, Pathologic; Endarterectomy; Female; F | 1984 |
[Development of corneal neovascularization following the occlusion of the posterior long ciliary arteries].
Topics: Animals; Ciliary Body; Cornea; Iris; Ischemia; Microscopy, Electron, Scanning; Neovascularization, P | 1983 |
Inhibitor of vascular endothelial cell growth in the lens.
Topics: Angiogenesis Inducing Agents; Animals; Cattle; Cell Division; Cells, Cultured; Dose-Response Relatio | 1984 |
New thoughts on ocular neovascularization: a neurally controlled regenerative process?
Topics: Animals; Cornea; Eye; Humans; Iris; Neovascularization, Pathologic; Rabbits; Regeneration; Retinal V | 1984 |
Neovascular glaucoma. Etiologic considerations.
Topics: Adult; Aged; Arteriosclerosis; Carotid Artery Diseases; Constriction, Pathologic; Diabetic Retinopat | 1984 |
Rubeosis iridis: preoperative iris fluorescein angiography and periocular steroids.
Topics: Diabetic Retinopathy; Drug Therapy, Combination; Fluorescein Angiography; Glaucoma; Humans; Iris; Ne | 1984 |
Anterior segment complications and neovascular glaucoma following implantation of a posterior chamber intraocular lens.
Topics: Anterior Chamber; Ciliary Body; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lenses, Intrao | 1984 |
The lens capsule and rubeosis iridis: an angiographic study.
Topics: Animals; Cataract Extraction; Fluorescein Angiography; Humans; Iris; Iris Diseases; Lens Capsule, Cr | 1984 |
Hematoporphyrin photoradiation therapy for iris neovascularization. A preliminary report.
Topics: Animals; Hematoporphyrin Derivative; Hematoporphyrins; Iris; Macaca fascicularis; Neovascularization | 1984 |
Neovascular glaucoma associated with ocular hypoperfusion secondary to carotid artery disease.
Topics: Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Revascularization; Constriction, Patholo | 1984 |
Detection of angiogenesis activity in malignant bladder tissue and cells.
Topics: Animals; Carcinoma, Transitional Cell; Cell Line; Collagen; Humans; Iris; Mice; Mice, Nude; Neoplasm | 1984 |
Laser therapy for eye disorders.
Topics: Diabetic Retinopathy; Eye Diseases; Glaucoma; Humans; Iris; Laser Therapy; Macular Degeneration; Neo | 1984 |
Comparison between efficacy of full- and mild-scatter (panretinal) photocoagulation on the course of diabetic rubeosis iridis.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Iris; Light Coagulation; Male; | 1993 |
Role of anterior retinal cryoablation in the management of neovascular glaucoma.
Topics: Adolescent; Adult; Aged; Cryosurgery; Female; Fluorescein Angiography; Follow-Up Studies; Glaucoma, | 1993 |
Central vein occlusion study of photocoagulation. Manual of operations. Central Vein Occlusion Study Group.
Topics: Adult; Clinical Protocols; Glaucoma, Neovascular; Humans; Iris; Ischemia; Laser Coagulation; Macular | 1993 |
Structure of the vitreoretinal border region in spontaneously diabetic BB rats.
Topics: Animals; Basement Membrane; Diabetes Mellitus; Female; Iris; Male; Neovascularization, Pathologic; R | 1993 |
[Results of laser coagulation of central retinal vein occlusion].
Topics: Fluorescein Angiography; Follow-Up Studies; Glaucoma, Angle-Closure; Humans; Iris; Ischemia; Laser C | 1993 |
Chronic ocular ischemia associated with the Eisenmenger's syndrome.
Topics: Adult; Aneurysm; Chronic Disease; Eisenmenger Complex; Eye; Female; Humans; Hypoxia; Iris; Ischemia; | 1994 |
Aqueous humour lactic acid and proteins in eyes with iris neovascularization.
Topics: Adult; Aged; Aged, 80 and over; Aqueous Humor; Cataract; Eye Proteins; Humans; Iris; Lactates; Lacti | 1994 |
Iris pigmentation and extent of disease in patients with neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Eye Color; Female; Humans; Iris; Macular Degeneration; Male; Middl | 1994 |
Surgical avulsion of the iris to treat selected cases of neovascular glaucoma.
Topics: Adult; Cataract; Cell Membrane; Diabetic Retinopathy; Female; Follow-Up Studies; Glaucoma, Neovascul | 1994 |
Nicotine on the revascularization of bone graft. An experimental study in rabbits.
Topics: Animals; Bone and Bones; Bone Transplantation; Fluorescein Angiography; Iris; Microcirculation; Neov | 1994 |
Hypoperfusion of the iris and its consequences in anterior segment pigment dispersal syndrome.
Topics: Adult; Aged; Anterior Eye Segment; Female; Fluorescein Angiography; Glaucoma, Open-Angle; Humans; In | 1994 |
Central retinal vein occlusion, an investigation by color Doppler imaging. Blood velocity characteristics and prediction of iris neovascularization.
Topics: Adult; Aged; Aged, 80 and over; Blood Flow Velocity; Female; Humans; Iris; Ischemia; Male; Middle Ag | 1994 |
Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.
Topics: Animals; Disease Models, Animal; Endothelial Growth Factors; Eye Diseases; Iris; Ischemia; Lymphokin | 1994 |
The care and fitting of Naka-Rushton functions to electroretinographic intensity-response data.
Topics: Adult; Aged; Algorithms; Diagnosis, Computer-Assisted; Electroretinography; Humans; Iris; Middle Age | 1993 |
[Ischemic or non-ischemic central artery occlusion. An explanation for the development or lack of development of neovascularization].
Topics: Blood Flow Velocity; Carotid Artery, Internal; Carotid Stenosis; Fluorescein Angiography; Humans; In | 1994 |
Biomicroscopy and fluorescein angiography of pigmented iris tumors. A retrospective study on 44 cases.
Topics: Female; Fluorescein Angiography; Humans; Iris; Iris Neoplasms; Male; Melanoma; Microscopy; Middle Ag | 1994 |
Panretinal cryopexy for the management of neovascularization of the iris.
Topics: Aged; Cryosurgery; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Humans; Iris; Iris Diseases; | 1995 |
Infrared angiography of the anterior ocular segment.
Topics: Adult; Aged; Anterior Eye Segment; Diabetic Retinopathy; Exfoliation Syndrome; Fluorescein; Fluoresc | 1995 |
Diabetic iris neovascularization.
Topics: Diabetes Complications; Female; Glaucoma, Neovascular; Gonioscopy; Humans; Iris; Laser Coagulation; | 1995 |
Feasibility of laser targeted photo-occlusion of ocular vessels.
Topics: Animals; Feasibility Studies; Fluorescent Dyes; Indoles; Iris; Lasers; Liposomes; Male; Neovasculari | 1995 |
Immunohistochemical evaluation of the integrity of the blood-aqueous barrier in normal and rubeotic human eyes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Anterior Chamber; Aqueous Humor; Blood; Capill | 1995 |
Regression of experimental iris neovascularization with systemic alpha-interferon.
Topics: Animals; Disease Models, Animal; Fluorescein Angiography; Interferon alpha-2; Interferon-alpha; Iris | 1993 |
Anterior hyaloidal fibrovascular proliferation after extracapsular cataract extraction in diabetic eyes.
Topics: Aged; Anterior Eye Segment; Cataract Extraction; Diabetic Retinopathy; Eye Diseases; Female; Fluores | 1993 |
Electroretinographic findings in iris neovascularization due to acute central retinal vein occlusion.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Electroretinography; Follow-Up Studies; Humans; Iris; | 1993 |
Combined central retinal artery-central vein obstruction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Hu | 1993 |
Influence of silicone oil on iris microangiopathy in diabetic vitrectomized eyes.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Complications; Diabetic Angiopathies; Female; Fluorescein A | 1993 |
Predicting outcome in central retinal vein occlusion using the flicker electroretinogram.
Topics: Dark Adaptation; Electroretinography; Humans; Iris; Light; Neovascularization, Pathologic; Predictiv | 1993 |
[Inhibitory effect of prior panretinal photocoagulation on experimental iris neovascularization].
Topics: Animals; Iris; Light Coagulation; Macaca mulatta; Neovascularization, Pathologic; Retina | 1993 |
Are there medical conditions specifically underlying the development of rubeosis in central retinal vein occlusion?
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Diabetes Complications; Female; Glaucoma, Neovasc | 1993 |
Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate.
Topics: Animals; Antibodies, Monoclonal; Blotting, Northern; Capillary Permeability; Endothelial Growth Fact | 1996 |
Crossed polarising filters to measure relative afferent pupillary defects: reproducibility, correlation with neutral density filters and use in central retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Female; Filtration; Humans; Iris; Light; Male; Middle Aged; Neovascu | 1995 |
Rod photoreceptor transduction is affected in central retinal vein occlusion associated with iris neovascularization.
Topics: Adult; Aged; Aged, 80 and over; Electroretinography; Forecasting; Humans; Iris; Middle Aged; Neovasc | 1996 |
Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis.
Topics: Alternative Splicing; Amino Acid Sequence; Animals; Base Sequence; Blotting, Southern; Cloning, Mole | 1996 |
Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Topics: Animals; Capillary Permeability; Dose-Response Relationship, Drug; Endothelial Growth Factors; Fluor | 1996 |
Iris indocyanine green videoangiography in diabetic iridopathy.
Topics: Aged; Case-Control Studies; Coloring Agents; Diabetic Retinopathy; Feasibility Studies; Female; Fluo | 1996 |
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.
Topics: Adult; Aged; Aged, 80 and over; Blood Coagulation; Blood Viscosity; Case-Control Studies; Female; Hu | 1996 |
Regression of rubeosis iridis after trabeculectomy combined with mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Combined Modality Therapy; Female; Follow-Up Studies; Glaucoma; H | 1996 |
Rubeosis of the iris in proliferative vitreoretinopathy.
Topics: Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glaucoma, Neovascular; Humans; Iris; Light | 1996 |
Endoscopic fluorescein angiography.
Topics: Choroid Diseases; Endoscopy; Fluorescein; Fluorescein Angiography; Fluoresceins; Fluorescent Dyes; F | 1996 |
Disorders of perfusion of the anterior segment of the eye.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anterior Eye Segment; Atrophy; Chronic Disease; Femal | 1996 |
Electroretinography of central retinal vein occlusion under scotopic and photopic conditions: what to measure?
Topics: Adaptation, Ocular; Adult; Aged; Aged, 80 and over; Dark Adaptation; Electroretinography; Female; Hu | 1997 |
Diabetic iris neovascularization. Natural history and treatment.
Topics: Cryotherapy; Diabetes Complications; Disease Progression; Female; Follow-Up Studies; Glaucoma, Neova | 1997 |
Case of rubeosis in association with proliferative vitreoretinopathy (PVR)
Topics: Fluorescein Angiography; Fundus Oculi; Glaucoma, Neovascular; Humans; Iris; Laser Coagulation; Neova | 1997 |
Rubeosis iridis in retinoblastoma. Histologic findings and the possible role of vascular endothelial growth factor in its induction.
Topics: Child; Child, Preschool; Endothelial Growth Factors; Eye Neoplasms; Female; Humans; In Situ Hybridiz | 1997 |
Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative.
Topics: Angiography, Digital Subtraction; Animals; Coloring Agents; Fluorescein Angiography; Indocyanine Gre | 1997 |
Peripheral transscleral retinal diode laser for rubeosis iridis.
Topics: Adult; Aged; Aged, 80 and over; Ciliary Body; Female; Humans; Intraocular Pressure; Iris; Laser Coag | 1997 |
Evaluation of Nd:YAG laser membranectomy in blocked tubes after glaucoma tube-shunt surgery.
Topics: Aged; Evaluation Studies as Topic; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 1997 |
Iridopathy in eyes with proliferative diabetic retinopathy: detection of early stage of rubeosis iridis.
Topics: Aged; Blood-Aqueous Barrier; Diabetic Retinopathy; Fluorescein Angiography; Humans; Iris; Iris Disea | 1998 |
Cataract extraction in eyes with diabetic iris neovascularization.
Topics: Adult; Aged; Aged, 80 and over; Cataract Extraction; Diabetic Retinopathy; Female; Follow-Up Studies | 1998 |
Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma.
Topics: Aged; Aged, 80 and over; Aqueous Humor; Cataract; Endothelial Growth Factors; Enzyme-Linked Immunoso | 1998 |
The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion.
Topics: Acute Disease; Adult; Aged; Anterior Eye Segment; Female; Follow-Up Studies; Glaucoma, Neovascular; | 1998 |
Peripheral transscleral retinal diode laser for rubeosis iridis.
Topics: Glaucoma, Neovascular; Humans; Iris; Laser Therapy; Neovascularization, Pathologic; Sclera | 1998 |
Neovascular complications associated with rubeosis iridis and peripheral retinal detachment after retinal detachment surgery.
Topics: Adult; Aged; Female; Humans; Iris; Iris Diseases; Male; Middle Aged; Neovascularization, Pathologic; | 1998 |
Capillary nonperfusion of the retina in diabetes mellitus.
Topics: Adult; Capillaries; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Fluorescein Angiography; Humans | 1998 |
Rubeosis iridis after vitrectomy for diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Glaucoma, Neovascular; Humans; Inciden | 1998 |
Iris neovascularization following branch retinal artery occlusion.
Topics: Aged; Anterior Eye Segment; Blood Flow Velocity; Carotid Artery, Common; Carotid Stenosis; Fluoresce | 1998 |
[Vitrectomy for proliferative diabetic retinopathy associated with iris rubeosis].
Topics: Diabetic Retinopathy; Female; Humans; Iris; Male; Middle Aged; Neovascularization, Pathologic; Vitre | 1999 |
Fluorescein angiography of extreme peripheral retina and rubeosis iridis in proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Diabetic Retinopathy; Female; Fluorescein Angiography; Fundus Oculi; | 1999 |
Increased interleukin-6 in aqueous humor of neovascular glaucoma.
Topics: Aged; Aqueous Humor; Enzyme-Linked Immunosorbent Assay; Female; Glaucoma, Neovascular; Humans; Inter | 1999 |
[Consensus on neovascular glaucoma].
Topics: Adult; Age Factors; Aged; Diabetic Retinopathy; Electroretinography; Glaucoma, Neovascular; Humans; | 2000 |
The 30-Hz flicker cone ERG for monitoring the early course of central retinal vein occlusion.
Topics: Aged; Electroretinography; Female; Humans; Iris; Male; Middle Aged; Neovascularization, Pathologic; | 2000 |
[Development of neovascularization of the optic papilla, retina and iris. Dependence on site and extent of retinal ischemia].
Topics: Diabetic Retinopathy; Fluorescein Angiography; Humans; Iris; Ischemia; Neovascularization, Pathologi | 2000 |
Bilateral iris neovascularization as the initial sign of obesity-hypoventilation (Pickwickian) syndrome: hypoxia/hypercapnia as a stimulus for angiogenesis.
Topics: Adult; Diagnosis, Differential; Fluorescein Angiography; Humans; Hypercapnia; Hypoxia; Intermittent | 2000 |
Central retinal vein occlusion in a patient with thrombotic thrombocytopenic purpura.
Topics: Acute Disease; Blood Flow Velocity; Female; Humans; Iris; Laser Coagulation; Middle Aged; Neovascula | 2001 |
Photopic 30 Hz flicker ERG as a predictor for rubeosis in central retinal vein occlusion.
Topics: Adult; Aged; Electroretinography; Female; Humans; Iris; Male; Middle Aged; Neovascularization, Patho | 2001 |
Nine year follow-up study of morbidity and mortality in retinal vein occlusion.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Comorbidity; Diabetes Melli | 2000 |
Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy.
Topics: Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Diabetic Retinopathy; Female; Fluorescein A | 2001 |
VEGFR-3 in adult angiogenesis.
Topics: Animals; Antibodies, Monoclonal; Carcinoma; Colonic Neoplasms; Glioma; Humans; Iris; Macaca fascicul | 2001 |
Plaque radiotherapy for choroidal hemangioma with total retinal detachment and iris neovascularization.
Topics: Brachytherapy; Choroid Neoplasms; Glaucoma, Neovascular; Hemangioma; Humans; Iodine Radioisotopes; I | 2001 |
Neovascularization in the anterior segment of the rabbit eye by experimental anterior ischemia.
Topics: Animals; Anterior Eye Segment; Atrophy; Blotting, Western; Ciliary Arteries; Ciliary Body; Electroco | 2002 |
Potential long-term inhibition of ocular neovascularisation by recombinant adeno-associated virus-mediated secretion gene therapy.
Topics: Adenoviridae; Animals; Cell Line; Cells, Cultured; Choroid; Endothelial Growth Factors; Endothelium, | 2002 |
Fluorescence iris angiography in the assessment of calcium dobesilate therapy in the treatment of diabetic microangiopathy.
Topics: Adult; Aneurysm; Benzenesulfonates; Calcium Dobesilate; Diabetic Angiopathies; Fluorescein Angiograp | 1979 |
Fluorescein angiography and changes in aqueous humor protein after argon laser photomydriasis in rabbits.
Topics: Animals; Aqueous Humor; Capillaries; Eye Proteins; Female; Fluorescein Angiography; Iris; Laser Ther | 1979 |
Iris neovascular tufts. Relationship to rubeosis, insulin, and hypotony.
Topics: Adolescent; Adult; Aged; Capillary Permeability; Diabetic Angiopathies; Female; Glucose Tolerance Te | 1979 |
[Pan-retinal photocoagulation and rubeosis iridis].
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Iris; Light Coagulation; Male; Middle Aged; Neova | 1979 |
Vitrectomy after intracapsular cataract extraction in diabetic sequelae.
Topics: Adult; Aged; Cataract Extraction; Diabetes Complications; Diabetic Retinopathy; Eye; Female; Fluores | 1979 |
Stickler's syndrome and neovascular glaucoma.
Topics: Adult; Female; Fluorescein Angiography; Glaucoma; Humans; Iris; Neovascularization, Pathologic; Pedi | 1979 |
Infrequency of retinal neovascularization following central retinal vein occlusion.
Topics: Humans; Iris; Neovascularization, Pathologic; Retinal Hemorrhage; Retinal Vein; Retinal Vessels; Uve | 1979 |
Infrequency of retinal neovascularization following central retinal vein occlusion attributed to endothelial death.
Topics: Capillaries; Cell Survival; Constriction, Pathologic; Endothelium; Humans; Iris; Neovascularization, | 1979 |
Panretinal photocoagulation and optic disc neovascularization.
Topics: Adult; Aged; Follow-Up Studies; Humans; Iris; Light Coagulation; Middle Aged; Neovascularization, Pa | 1979 |
The treatment of angle neovascularization with panretinal photocoagulation.
Topics: Adult; Aged; Anterior Chamber; Female; Fluorescein Angiography; Humans; Intraocular Pressure; Iris; | 1979 |
Atypical parafoveal telangiectasis with subsequent anterior and posterior segment neovascularization.
Topics: Fluorescein Angiography; Fovea Centralis; Fundus Oculi; Humans; Iris; Laser Coagulation; Male; Middl | 1992 |
[Dynamics of vascular changes in neovascular glaucoma. I. Development of rubeosis iridis after cryosurgery].
Topics: Cryosurgery; Glaucoma, Neovascular; Humans; Iris; Neovascularization, Pathologic | 1992 |
[Dynamics of vascular changes in neovascular glaucoma. II. Unusual findings after cryosurgery].
Topics: Cryosurgery; Glaucoma, Neovascular; Humans; Iris; Neovascularization, Pathologic | 1992 |
Acute onset of rubeosis iridis after diabetic vitrectomy can indicate peripheral traction retinal detachment.
Topics: Acute Disease; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Intraocular Pressure; Iris; | 1992 |
Interferon may offer first drug therapy for diabetic retinopathy. New research showing that alpha-interferon blocks new blood vessel formation in the iris of monkeys may point the way to new treatment for diabetes retinopathy.
Topics: Animals; Diabetic Retinopathy; Haplorhini; Humans; Interferon-alpha; Iris; Neovascularization, Patho | 1992 |
An experimental model of ectropion uveae and iris neovascularization in the cat.
Topics: Animals; Cats; Cautery; Disease Models, Animal; Ectropion; Iris; Lens, Crystalline; Neovascularizati | 1992 |
[Morphological study of rubeosis iridis induced in animal eyes].
Topics: Animals; Constriction; Disease Models, Animal; Intraocular Pressure; Iris; Macaca mulatta; Neovascul | 1992 |
Iris neovascularization in proliferative vitreoretinopathy.
Topics: Adolescent; Adult; Aged; Child; Eye Diseases; Humans; Incidence; Iris; Male; Middle Aged; Neovascula | 1992 |
Spontaneous hyphema: an unusual complication of uveitis associated with ankylosing spondylitis.
Topics: Adult; Corneal Edema; HLA-B27 Antigen; Humans; Hyphema; Iris; Male; Neovascularization, Pathologic; | 1992 |
[Effect of pan-retinal photocoagulation in iris neovascularization].
Topics: Animals; Iris; Light Coagulation; Macaca mulatta; Microscopy, Electron; Neovascularization, Patholog | 1992 |
Histopathological findings in the iris of dapsone treated leprosy patients.
Topics: Adult; Aged; Aged, 80 and over; Atrophy; Dapsone; Female; Humans; Iris; Iritis; Leprosy; Male; Middl | 1990 |
Iris neovascularization after central retinal artery obstruction despite previous panretinal photocoagulation for diabetic retinopathy.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Intraocular Pressure; Ir | 1990 |
Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Topics: Diabetic Retinopathy; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factors; Humans; Iris; Ne | 1990 |
Accelerated ocular neovascularisation in diabetics following posterior chamber lens implantation.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Iris; Lenses, Intraocular; Male; Neov | 1990 |
The development and management of neovascular glaucoma.
Topics: Adult; Aged; Aged, 80 and over; Cell Count; Diabetic Retinopathy; Endothelium, Corneal; Female; Fluo | 1990 |
Combined branch retinal artery and central retinal vein obstruction.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Fundus Oculi; Humans; Iris; Light C | 1990 |
Rubeosis capsulare.
Topics: Cryosurgery; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Hyphema; Iris; Lens Caps | 1990 |
A prospective study of acute central retinal artery obstruction. The incidence of secondary ocular neovascularization.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Carotid Artery Diseases; Female; Glaucoma, Neovascula | 1991 |
Spontaneous dural carotid-cavernous fistula with central retinal vein occlusion and iris neovascularization.
Topics: Arteriovenous Fistula; Carotid Artery Diseases; Cavernous Sinus; Diagnosis, Differential; Female; Fl | 1991 |
[Epidemiology, invasion and growth of non-iridic choroid melanomas and associated intraocular changes: histologic study of 223 eyes].
Topics: Adult; Aged; Aged, 80 and over; Cell Division; Cell Transformation, Neoplastic; Choroid; Choroid Neo | 1990 |
Profound central visual loss and ocular neovascularization in idiopathic recurrent branch retinal arterial occlusion.
Topics: Aged; Blindness; Glaucoma; Humans; Iris; Male; Neovascularization, Pathologic; Optic Disk; Recurrenc | 1990 |
Retinal hemangioma-like lesions in eyes with retinitis pigmentosa.
Topics: Adrenal Cortex Hormones; Adult; Atropine; Female; Fluorescein Angiography; Fundus Oculi; Hemangioma; | 1990 |
Ultrastructure and blood-iris barrier in experimental rubeosis iridis in rabbit.
Topics: Animals; Biological Transport, Active; Disease Models, Animal; Horseradish Peroxidase; Iris; Iritis; | 1990 |
[Ocular complications of diabetes mellitus--classification and diagnosis].
Topics: Cataract; Corneal Diseases; Diabetes Complications; Diabetic Retinopathy; Eye Diseases; Glaucoma; Hu | 1991 |
A prospective evaluation of anterior retinal cryoablation in neovascular glaucoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cryosurgery; Evaluation Studies as Topic; Female; | 1991 |
Risk of missing angle neovascularization by omitting screening gonioscopy in patients with diabetes mellitus.
Topics: Anterior Eye Segment; Diabetes Complications; Humans; Iris; Neovascularization, Pathologic; Risk Fac | 1991 |
Neovascular response in ischaemic central retinal vein occlusion after panretinal photocoagulation.
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Humans; Iris; Ischemia; Light Coagulation; | 1991 |
Neovascularization of the iris in rhegmatogenous retinal detachment.
Topics: Age Factors; Humans; Incidence; Iris; Middle Aged; Neovascularization, Pathologic; Postoperative Com | 1991 |
Electroretinogram b-wave implicit time and b/a wave ratio as a function of intensity in central retinal vein occlusion.
Topics: Aged; Electroretinography; Humans; Iris; Neovascularization, Pathologic; Predictive Value of Tests; | 1991 |
Phthalocyanine photodynamic therapy of experimental iris neovascularization.
Topics: Aluminum; Animals; Corneal Diseases; Disease Models, Animal; Endothelium, Corneal; Fluorescein Angio | 1991 |
[Filtration angles in pseudophakic eyes].
Topics: Adolescent; Adult; Aged; Anterior Chamber; Eye Diseases; Humans; Iris; Iris Diseases; Lenses, Intrao | 1991 |
[Experimental study of the occurrence of iris neovascularization in monkey eyes].
Topics: Animals; Aphakia; Iris; Lasers; Light Coagulation; Macaca; Neovascularization, Pathologic; Retinal V | 1985 |
Nodular adenomatosis of iris pigment epithelium.
Topics: Adenoma; Cytoplasmic Granules; Fluorescein Angiography; Humans; Iris; Iris Diseases; Male; Melanins; | 1985 |
On the pathology of the ciliary sulcus.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Ciliary Body; Diabetic Retinopathy; Glaucoma; Huma | 1985 |
[Unusual technics for argon photocoagulation of the anterior segment].
Topics: Acute Disease; Anterior Chamber; Anterior Eye Segment; Cysts; Eye Diseases; Glaucoma; Humans; Iris; | 1985 |
Arteriovenous malformations of the iris.
Topics: Arteriovenous Malformations; Diagnosis, Differential; Female; Fluorescein Angiography; Follow-Up Stu | 1985 |
Management of vitreous cavity hemorrhage following pars plana vitrectomy for diabetic retinopathy.
Topics: Air; Diabetic Retinopathy; Drainage; Eye Diseases; Hemorrhage; Humans; Injections; Iris; Neovascular | 1986 |
Fundus-iris fluorescein angiography: evaluation of its use in the diagnosis of rubeosis iridis.
Topics: Aged; Evaluation Studies as Topic; Fluorescein Angiography; Follow-Up Studies; Humans; Iris; Male; M | 1986 |
[Vitrectomy and subsequent photocoagulation in proliferative diabetic retinopathy with vitreous hemorrhage].
Topics: Adult; Aged; Cataract; Combined Modality Therapy; Diabetic Retinopathy; Follow-Up Studies; Humans; I | 1986 |
The visual outcome in cases of neovascular glaucoma.
Topics: Adult; Aged; Anterior Chamber; Combined Modality Therapy; Drainage; Female; Glaucoma; Glaucoma, Open | 1985 |
Fluorescein angiography of the iris in anterior segment pigment dispersal syndrome.
Topics: Cell Count; Cornea; Endothelium; Eye Color; Fluorescein Angiography; Iris; Iris Diseases; Neovascula | 1986 |
Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma.
Topics: Cell Survival; Cells, Cultured; Chromosome Aberrations; Chromosome Disorders; Eye Neoplasms; Female; | 1986 |
Optic disk and iris neovascularization after surgical interruption of the retinal circulation.
Topics: Adult; Constriction; Eye Diseases; Female; Humans; Iris; Neovascularization, Pathologic; Optic Disk; | 1986 |
Neovascular glaucoma following neodymium-YAG laser posterior capsulotomy.
Topics: Cataract Extraction; Diabetes Mellitus, Type 1; Female; Glaucoma; Humans; Iris; Laser Therapy; Lens | 1986 |
[Vitrectomy and complications of proliferating diabetic retinopathy].
Topics: Adult; Aged; Diabetic Retinopathy; Eye Diseases; Female; Hemorrhage; Humans; Iris; Male; Middle Aged | 1985 |
Primate model of neovascular glaucoma.
Topics: Animals; Disease Models, Animal; Eye; Fluorescein Angiography; Glaucoma; Iris; Lasers; Lens, Crystal | 1986 |
Hypotony and experimental rubeosis iridis in primate eyes. A clinicopathologic study.
Topics: Animals; Intraocular Pressure; Iris; Macaca fascicularis; Microscopy, Electron; Neovascularization, | 1986 |
[Intraocular pulse fluctuations in pressure in neovascularization glaucoma in comparison to other forms of glaucoma (results of direct manometric measurements)].
Topics: Anterior Chamber; Blood Pressure; Diabetic Retinopathy; Eye Injuries; Glaucoma; Glaucoma, Open-Angle | 1986 |
Differential diagnosis of spontaneous hyphema associated with central retinal vein occlusion.
Topics: Aged; Diagnosis, Differential; Glaucoma; Humans; Hyphema; Iris; Male; Neovascularization, Pathologic | 1986 |
[Experiences with a modified, intraocular pressure-reducing excision of the ciliary body].
Topics: Ciliary Body; Cryosurgery; Diabetic Retinopathy; Follow-Up Studies; Glaucoma; Humans; Intraocular Pr | 1986 |
Neovascular glaucoma as a complication of the Wyburn-Mason syndrome.
Topics: Child, Preschool; Choroid; Female; Glaucoma; Humans; Intracranial Arteriovenous Malformations; Iris; | 1985 |
Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula.
Topics: Adolescent; Adult; Aged; Cataract; Diabetic Retinopathy; Humans; Iris; Macula Lutea; Middle Aged; Ne | 1987 |
Results and prognostic factors in vitrectomy for diabetic traction-rhegmatogenous retinal detachment.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Humans; Iris; Male; Middle Aged; Neovascularization, Path | 1987 |
Effects of extracapsular cataract extraction with posterior chamber lens implantation on the development of neovascular glaucoma in diabetics.
Topics: Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glaucoma; Humans; Iris; Lenses, | 1987 |
[Photocoagulation in diabetic rubeosis iridis and neovascular glaucoma].
Topics: Diabetic Retinopathy; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Iris; Laser | 1987 |
Silicone oil with high specific gravity for intraocular use.
Topics: Animals; Cornea; Corneal Diseases; Dimethylpolysiloxanes; Eye; Iris; Iris Diseases; Neovascularizati | 1987 |
Central retinal artery occlusion with an irido-embolus following carotid endarterectomy.
Topics: Aged; Arterial Occlusive Diseases; Carotid Artery Diseases; Carotid Artery, Internal; Constriction, | 1987 |
Neovascular glaucoma: a retrospective analysis of treatment with peripheral panretinal cryotherapy.
Topics: Aged; Aged, 80 and over; Cryosurgery; Diabetic Retinopathy; Female; Glaucoma; Humans; Iris; Male; Mi | 1987 |
Scanning electron microscopy of microcorrosion casts: applications in ophthalmologic research.
Topics: Animals; Cats; Choroid; Ciliary Body; Eye; Eye Diseases; Humans; Iris; Microcirculation; Microscopy, | 1987 |
Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis.
Topics: Animals; Cebus; Disease Models, Animal; Fluorescein Angiography; Iris; Iris Diseases; Ischemia; Neov | 1987 |
Progressive corneal endothelial cell changes in anterior segment disease.
Topics: Adult; Aged; Cell Count; Chronic Disease; Cornea; Endothelium; Female; Humans; Iris; Male; Microcirc | 1987 |
New clinical classification for iris neovascularization.
Topics: Aged; Humans; Intraocular Pressure; Iris; Light Coagulation; Male; Neovascularization, Pathologic | 1987 |
Adjusting the dose of 5-fluorouracil after filtration surgery to minimize side effects.
Topics: Adult; Aged; Female; Fluorouracil; Glaucoma; Humans; Inflammation; Intraocular Pressure; Iris; Male; | 1987 |
Increased intraocular pressure following endarterectomy.
Topics: Carotid Artery Diseases; Endarterectomy; Glaucoma; Humans; Intraocular Pressure; Iris; Male; Middle | 1987 |
Iris atrophy with hypoperfusion and microneovascularisation.
Topics: Aged; Aged, 80 and over; Angiography; Atrophy; Female; Glaucoma; Humans; Iris; Male; Neovascularizat | 1987 |
Long-term results of modified trabeculectomy with supramid implant for neovascular glaucoma.
Topics: Glaucoma; Humans; Intraocular Pressure; Iris; Neovascularization, Pathologic; Nylons; Postoperative | 1987 |
[The fluoroangiographic picture of the iris in pseudoexfoliative glaucoma].
Topics: Aged; Aged, 80 and over; Female; Fluorescein Angiography; Glaucoma; Humans; Iris; Lens Diseases; Mal | 1987 |
Anterior segment ischemia after recession of various recti. An experimental study.
Topics: Animals; Anterior Eye Segment; Arteries; Cataract; Ciliary Body; Cornea; Fluorescein Angiography; In | 1987 |
The development of microneovascular changes in the iris in pseudoexfoliation of the lens capsule.
Topics: Aged; Aged, 80 and over; Cell Count; Endothelium; Female; Fluorescein Angiography; Humans; Iris; Len | 1987 |
Silicone oil in the treatment of complicated retinal detachments.
Topics: Diabetic Retinopathy; Drainage; Eye; Eye Diseases; Humans; Injections; Iris; Neovascularization, Pat | 1987 |
Following up patients with central retinal vein occlusion.
Topics: Electroretinography; Follow-Up Studies; Humans; Iris; Neovascularization, Pathologic; Retinal Vein O | 1988 |
Neovascularization in central retinal vein occlusion: electroretinographic findings.
Topics: Electroretinography; Fluorescein Angiography; Humans; Iris; Neovascularization, Pathologic; Retinal | 1988 |
Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis.
Topics: Electroretinography; Forecasting; Humans; Iris; Lighting; Neovascularization, Pathologic; Retinal Ve | 1988 |
Panretinal cryotherapy in neovascular disease.
Topics: Adult; Aged; Aged, 80 and over; Cryosurgery; Diabetic Retinopathy; Female; Glaucoma; Humans; Iris; M | 1988 |
Importance of medical treatment in retinal vein occlusion.
Topics: Adult; Aged; Combined Modality Therapy; Female; Humans; Iris; Male; Neovascularization, Pathologic; | 1987 |
Central retinal vein occlusion and iris neovascularization hemorrhage.
Topics: Humans; Hyphema; Iris; Male; Middle Aged; Neovascularization, Pathologic; Retinal Vein Occlusion | 1988 |
[Retinal cryocoagulation in rubeosis iridis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cryosurgery; Diabetic Retinopathy; Follow-Up Studies; Hu | 1988 |
Vascular response in a non-uterine site to implantation-stage embryos in the rat and guinea-pig: in vivo and ultrastructural studies.
Topics: Animals; Embryo Implantation; Embryo Transfer; Female; Guinea Pigs; Iris; Microscopy, Electron; Neov | 1988 |
[Effect of rubeosis iridis and active neovascularization of the fundus on vitreous surgery in diabetic retinopathy].
Topics: Adult; Aged; Diabetic Retinopathy; Humans; Intraoperative Complications; Iris; Middle Aged; Neovascu | 1988 |
Iris neovascularization associated with obstruction of the central retinal artery.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Iris; Ma | 1988 |
The efficacy of panretinal photocoagulation for neovascularization of the iris after central retinal artery obstruction.
Topics: Aged; Aged, 80 and over; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Laser Therapy; Light | 1989 |
Factors influencing the results of vitreous surgery in diabetic retinopathy. I. Iris rubeosis and/or active neovascularization at the fundus.
Topics: Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Fundus Oculi; Humans; Iris; Macula Lut | 1989 |
Proliferative sarcoid retinopathy.
Topics: Adult; Female; Fluorescein Angiography; Humans; Iris; Light Coagulation; Male; Middle Aged; Neovascu | 1988 |
Cellular mechanisms of iris neovascularization secondary to retinal vein occlusion.
Topics: Animals; Autoradiography; Biomechanical Phenomena; Fluorescein Angiography; Fundus Oculi; Iris; Maca | 1989 |
Pars plana vitrectomy and silicone oil injection in proliferative diabetic retinopathy.
Topics: Adult; Aged; Combined Modality Therapy; Diabetic Retinopathy; Eye Hemorrhage; Humans; Injections; Ir | 1989 |
Silicone oil for the treatment of severe proliferative diabetic retinopathy.
Topics: Adolescent; Adult; Aged; Diabetic Retinopathy; Female; Follow-Up Studies; Glaucoma; Humans; Iris; Ma | 1989 |
Management of complicated retinal detachment by vitrectomy and silicone oil injection.
Topics: Adolescent; Adult; Diabetic Retinopathy; Eye Injuries; Female; Humans; Injections; Intraocular Press | 1988 |
[Morphological study of experimental corneal neovascularization after anterior uveal ischemia].
Topics: Animals; Ciliary Body; Cornea; Iris; Ischemia; Neovascularization, Pathologic; Neutrophils; Rabbits | 1989 |
Electroretinogram parameters at presentation as predictors of rubeosis in central retinal vein occlusion patients.
Topics: Aged; Data Interpretation, Statistical; Electroretinography; Female; Humans; Iris; Iris Diseases; Ma | 1989 |
[Early changes of the vascular system of the eye in hyperlipoproteinemia].
Topics: Adult; Aneurysm; Arteriosclerosis; Capillary Permeability; Cornea; Extravasation of Diagnostic and T | 1989 |
Mild diabetic rubeosis and panretinal photocoagulation.
Topics: Diabetic Retinopathy; Fluorescein Angiography; Humans; Iris; Light Coagulation; Neovascularization, | 1989 |
[Intraocular pressure during vitrectomy in the diabetic patient].
Topics: Adolescent; Adult; Aged; Diabetic Retinopathy; Female; Humans; Intraocular Pressure; Intraoperative | 1989 |
Diabetic choroidal and iris vasculature scanning electron microscopy findings.
Topics: Adult; Aged; Choroid; Ciliary Body; Diabetes Mellitus, Type 1; Female; Humans; Iris; Male; Microscop | 1989 |
Usual and unusual uses of the laser in glaucoma.
Topics: Ciliary Body; Cysts; Eye Abnormalities; Glaucoma; Humans; Iris; Iris Diseases; Laser Therapy; Light | 1985 |
Ocular neovascularization. Tissue culture studies.
Topics: Animals; Aqueous Humor; Cattle; Constriction; Culture Techniques; Glaucoma; Humans; Iris; Lens, Crys | 1985 |